0001829794 2026-01-01 2026-03-31 0001829794 2026-05-07 0001829794 2026-03-31 0001829794 2025-12-31 0001829794 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001829794 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001829794 2025-01-01 2025-03-31 0001829794 us-gaap:CommonStockMember 2025-12-31 0001829794 us-gaap:TreasuryStockCommonMember 2025-12-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001829794 us-gaap:RetainedEarningsMember 2025-12-31 0001829794 us-gaap:CommonStockMember 2024-12-31 0001829794 us-gaap:TreasuryStockCommonMember 2024-12-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001829794 us-gaap:RetainedEarningsMember 2024-12-31 0001829794 2024-12-31 0001829794 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001829794 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001829794 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001829794 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001829794 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001829794 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001829794 us-gaap:CommonStockMember 2026-03-31 0001829794 us-gaap:TreasuryStockCommonMember 2026-03-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001829794 us-gaap:RetainedEarningsMember 2026-03-31 0001829794 us-gaap:CommonStockMember 2025-03-31 0001829794 us-gaap:TreasuryStockCommonMember 2025-03-31 0001829794 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001829794 us-gaap:RetainedEarningsMember 2025-03-31 0001829794 2025-03-31 0001829794 EMPD:March2026UnitIssuanceMember 2026-01-01 2026-03-31 0001829794 EMPD:AtTheMoneyOfferingMember 2025-01-01 2025-03-31 0001829794 EMPD:Feb2025UnitIssuanceMember 2025-01-01 2025-03-31 0001829794 EMPD:AtTheMarketEquityOfferingMember 2025-01-01 2025-03-31 0001829794 EMPD:VenomEVLLCMember 2025-10-14 2025-10-15 0001829794 2025-07-02 0001829794 2025-08-06 2025-08-07 0001829794 2025-07-31 0001829794 2026-02-20 0001829794 2025-06-10 2025-06-11 0001829794 EMPD:DTCCStreetNameMember 2024-11-18 2024-11-19 0001829794 2024-12-06 0001829794 us-gaap:OperatingSegmentsMember 2026-01-01 2026-03-31 0001829794 us-gaap:CorporateAndOtherMember 2026-01-01 2026-03-31 0001829794 EMPD:Bitcoin1Member 2026-03-31 0001829794 EMPD:Bitcoin2Member 2026-03-31 0001829794 EMPD:MasterRepurchaseAgreementMember 2025-08-15 0001829794 EMPD:MasterRepurchaseAgreementMember 2025-08-14 2025-08-15 0001829794 EMPD:MasterRepurchaseAgreementMember 2025-09-17 2025-09-18 0001829794 EMPD:MasterRepurchaseAgreementMember 2025-09-21 2025-09-22 0001829794 EMPD:RepoFacilityMasterRepurchaseAgreementMember 2025-09-26 0001829794 EMPD:RepoFacilityMasterRepurchaseAgreementMember 2026-01-01 2026-03-31 0001829794 EMPD:RepoFacilityMasterRepurchaseAgreementMember 2025-09-25 2025-09-26 0001829794 EMPD:RepoFacilityMasterRepurchaseAgreementMember 2025-09-21 2025-09-22 0001829794 EMPD:MasterRepurchaseAgreementMember 2026-01-01 2026-03-31 0001829794 EMPD:DelayedDrawTermLoansMember EMPD:MasterRepurchaseAgreementMember 2025-10-12 0001829794 2026-02-04 0001829794 EMPD:DelayedDrawTermLoansMember EMPD:MasterRepurchaseAgreementMember 2026-03-31 0001829794 EMPD:DelayedDrawTermLoansMember EMPD:MasterRepurchaseAgreementMember 2026-01-01 2026-03-31 0001829794 EMPD:DelayedDrawTermLoansMember EMPD:MasterRepurchaseAgreementMember 2026-05-07 0001829794 srt:MaximumMember us-gaap:VehiclesMember EMPD:FinancingArrangementMember 2023-03-01 2023-03-31 0001829794 us-gaap:VehiclesMember EMPD:FinancingArrangementMember 2023-03-01 2023-03-31 0001829794 us-gaap:VehiclesMember EMPD:FinancingArrangementMember 2026-03-31 0001829794 EMPD:SeriesAWarrantMember 2026-03-31 0001829794 EMPD:SeriesAWarrantsMember 2025-12-31 0001829794 EMPD:SeriesAWarrantsMember 2026-01-01 2026-03-31 0001829794 EMPD:SeriesAWarrantsMember 2026-03-31 0001829794 EMPD:WarrantsMember EMPD:GeminiNuStarLLCMember 2025-07-13 0001829794 EMPD:FourBoardMembersMember EMPD:PrivatePlacementsMember 2025-07-15 2025-07-17 0001829794 EMPD:ReadHomerAndChauhanMember EMPD:PrivatePlacementsMember 2025-07-15 2025-07-17 0001829794 EMPD:MrLaneMember 2025-07-15 2025-07-17 0001829794 EMPD:MrLaneMember 2025-07-17 0001829794 EMPD:StockPlan2025Member EMPD:MrLaneMember 2025-07-15 2025-07-17 0001829794 EMPD:MrLaneMember EMPD:PrivatePlacementsMember 2025-07-15 2025-07-17 0001829794 EMPD:EAMMember EMPD:PrivatePlacementsMember 2025-07-15 2025-07-17 0001829794 EMPD:EAMMember 2026-03-31 0001829794 EMPD:PreFundedWarrants01Member EMPD:EAMMember 2026-03-31 0001829794 EMPD:PreFundedWarrants08Member EMPD:EAMMember 2026-03-31 0001829794 EMPD:PreFundedWarrants16Member EMPD:EAMMember 2026-03-31 0001829794 EMPD:PreFundedWarrants1856Member EMPD:EAMMember 2026-03-31 0001829794 EMPD:BoardOfDirectorsMember 2025-07-15 2025-07-17 0001829794 EMPD:BoardOfDirectorsMember EMPD:CommitteeFeesMember 2025-07-15 2025-07-17 0001829794 EMPD:ThankYouStudiosMember 2025-03-01 2025-03-31 0001829794 srt:ChiefExecutiveOfficerMember 2024-02-02 2024-02-03 0001829794 srt:ChiefExecutiveOfficerMember 2024-02-03 0001829794 srt:ChiefExecutiveOfficerMember EMPD:NewEmploymentAgreementMember 2024-01-29 2024-01-30 0001829794 srt:ChiefExecutiveOfficerMember EMPD:NewEmploymentAgreementMember 2024-01-30 0001829794 EMPD:StockPlan2025Member EMPD:MrKimMember EMPD:NewEmploymentAgreementMember 2024-01-29 2024-01-30 0001829794 EMPD:StockPlan2025Member EMPD:MrKimMember EMPD:NewEmploymentAgreementMember 2024-01-30 0001829794 srt:ChiefFinancialOfficerMember 2024-01-29 2024-01-30 0001829794 srt:ChiefFinancialOfficerMember EMPD:NewEmploymentAgreementMember 2024-01-29 2024-01-30 0001829794 srt:ChiefFinancialOfficerMember EMPD:NewEmploymentAgreementMember 2024-01-30 0001829794 EMPD:StockPlan2025Member EMPD:MrEndoMember EMPD:NewEmploymentAgreementMember 2024-01-29 2024-01-30 0001829794 EMPD:StockPlan2025Member EMPD:MrEndoMember EMPD:NewEmploymentAgreementMember 2024-01-30 0001829794 EMPD:MrSilverMember 2026-01-01 2026-03-31 0001829794 EMPD:MrDirectorMember 2026-01-01 2026-03-31 0001829794 EMPD:MrSilverMember 2026-03-31 0001829794 EMPD:MrDirectorMember 2026-03-31 0001829794 2025-08-27 2025-08-28 0001829794 us-gaap:PreferredStockMember 2026-03-31 0001829794 EMPD:March2026OfferingMember EMPD:CommonStockUnitsMember 2026-03-23 2026-03-24 0001829794 us-gaap:CommonStockMember EMPD:March2026OfferingMember EMPD:CommonStockUnitsMember 2026-03-23 2026-03-24 0001829794 EMPD:WarrantsMember EMPD:March2026OfferingMember EMPD:CommonStockUnitsMember 2026-03-23 2026-03-24 0001829794 EMPD:PreFundedWarrantsMember EMPD:March2026OfferingMember EMPD:CommonStockUnitsMember 2026-03-23 2026-03-24 0001829794 EMPD:PreFundedWarrantsMember us-gaap:SubsequentEventMember EMPD:March2026OfferingMember EMPD:CommonStockUnitsMember 2026-04-01 2026-05-07 0001829794 EMPD:July2025PrivatePlacementMember 2025-07-16 2025-07-17 0001829794 EMPD:PreFundedWarrantsMember EMPD:July2025PrivatePlacementMember 2025-07-16 2025-07-17 0001829794 EMPD:PreFundedWarrantsMember EMPD:July2025PrivatePlacementMember 2025-07-17 0001829794 EMPD:PreFundedWarrantsMember EMPD:July2025PrivatePlacementMember 2025-07-18 2025-12-31 0001829794 EMPD:PreFundedWarrantsMember EMPD:July2025PrivatePlacementMember 2026-01-01 2026-03-31 0001829794 EMPD:February2025StockSaleMember EMPD:CommonStockUnitsMember 2025-02-05 2025-02-06 0001829794 us-gaap:CommonStockMember EMPD:February2025StockSaleMember EMPD:CommonStockUnitsMember 2025-02-05 2025-02-06 0001829794 EMPD:WarrantsMember EMPD:February2025StockSaleMember EMPD:CommonStockUnitsMember 2025-02-05 2025-02-06 0001829794 EMPD:PreFundedWarrantsMember EMPD:February2025StockSaleMember EMPD:CommonStockUnitsMember 2025-02-05 2025-02-06 0001829794 EMPD:Warrants2Member EMPD:CommonStockUnitsMember 2025-02-06 0001829794 EMPD:PreFundedWarrantsMember EMPD:February2025StockSaleMember EMPD:CommonStockUnitsMember 2026-01-01 2026-03-31 0001829794 EMPD:PreFundedWarrantsMember 2026-01-01 2026-03-31 0001829794 EMPD:ATMMember 2024-01-01 2024-12-31 0001829794 EMPD:ATMMember EMPD:AegisCapitalCorpMember 2024-01-01 2024-12-31 0001829794 EMPD:ATMMember 2025-01-01 2025-03-31 0001829794 EMPD:ATMMember 2025-07-16 2025-07-17 0001829794 EMPD:ATMMember EMPD:AegisCapitalCorpMember 2025-07-16 2025-07-17 0001829794 EMPD:ATMMember 2026-01-01 2026-03-31 0001829794 2025-03-21 0001829794 EMPD:March2025StockBuybackProgramMember 2026-01-01 2026-03-31 0001829794 EMPD:March2025StockBuybackProgramMember EMPD:CommissionsPaidMember 2026-01-01 2026-03-31 0001829794 2025-07-24 0001829794 2025-10-10 0001829794 2026-02-02 0001829794 EMPD:NewRepurchaseProgramMember 2026-01-01 2026-03-31 0001829794 EMPD:NewRepurchaseProgramMember EMPD:CommissionsPaidMember 2026-01-01 2026-03-31 0001829794 2026-02-03 0001829794 us-gaap:SeriesAPreferredStockMember 2026-02-03 0001829794 EMPD:SeriesAWarrantsMember 2026-03-31 0001829794 EMPD:WarrantsMember 2026-03-31 0001829794 EMPD:PlacementAgentWarrantsMember 2026-03-31 0001829794 EMPD:GeminiWarrantsMember 2026-01-01 2026-03-31 0001829794 EMPD:PrivatePlacementsMember 2026-01-01 2026-03-31 0001829794 EMPD:MonteCarloSimulationMember 2026-01-01 2026-03-31 0001829794 2025-07-20 2025-12-31 0001829794 us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0001829794 EMPD:PlacementAgentWarrantsMember 2026-03-31 0001829794 EMPD:GeminiWarrantsMember 2026-03-31 0001829794 EMPD:ConsultantMember us-gaap:PrivatePlacementMember 2026-03-31 0001829794 EMPD:ConsultantMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0001829794 us-gaap:PrivatePlacementMember 2025-07-01 2025-09-30 0001829794 EMPD:DailyVWAP10Member 2026-01-01 2026-03-31 0001829794 EMPD:DailyVWAP15Member 2026-01-01 2026-03-31 0001829794 EMPD:DailyVWAP20Member 2026-01-01 2026-03-31 0001829794 EMPD:DailyVWAP25Member 2026-01-01 2026-03-31 0001829794 EMPD:DailyVWAP30Member 2026-01-01 2026-03-31 0001829794 EMPD:PreFundedCommonStockWarrantsMember 2025-12-31 0001829794 EMPD:PreFundedCommonStockWarrantsMember 2026-01-01 2026-03-31 0001829794 EMPD:PreFundedCommonStockWarrantsMember 2026-03-31 0001829794 EMPD:CommonStockWarrantsMember 2025-12-31 0001829794 EMPD:CommonStockWarrantsMember 2026-01-01 2026-03-31 0001829794 EMPD:CommonStockWarrantsMember 2026-03-31 0001829794 EMPD:StockPlan2025Member 2025-07-15 2025-07-17 0001829794 EMPD:StockPlan2025Member 2025-07-17 0001829794 EMPD:StockPlan2025Member 2025-07-18 2026-03-31 0001829794 EMPD:TwoExecutivesAndOneEmployeeMember EMPD:InducementStockOptionsMember 2026-01-01 2026-03-31 0001829794 EMPD:InducementStockOptionsMember 2026-01-01 2026-03-31 0001829794 EMPD:InducementStockOptionsMember 2026-03-31 0001829794 EMPD:ChiefSalesOfficerMember EMPD:InducementStockOptionsMember EMPD:Plan2021Member 2024-08-01 2024-08-31 0001829794 EMPD:ChiefSalesOfficerMember EMPD:InducementStockOptionsMember 2025-06-01 2025-06-30 0001829794 EMPD:ChiefSalesOfficerMember EMPD:InducementStockOptionsMember 2026-01-01 2026-03-31 0001829794 EMPD:Volcon2021PlanMember 2021-01-31 0001829794 EMPD:Volcon2021PlanMember 2026-03-31 0001829794 EMPD:CEOAndCFOMember 2026-01-01 2026-03-31 0001829794 EMPD:CEOAndCFOMember 2026-03-31 0001829794 EMPD:CEOAndCFOMember 2025-01-01 2025-12-31 0001829794 EMPD:CEOAndCFOMember 2025-07-17 0001829794 us-gaap:StockOptionMember 2025-12-31 0001829794 us-gaap:StockOptionMember 2026-01-01 2026-03-31 0001829794 us-gaap:StockOptionMember 2026-03-31 0001829794 EMPD:CostOfGoodsSoldMember 2026-01-01 2026-03-31 0001829794 EMPD:CostOfGoodsSoldMember 2025-01-01 2025-03-31 0001829794 EMPD:SalesAndMarketingMember 2026-01-01 2026-03-31 0001829794 EMPD:SalesAndMarketingMember 2025-01-01 2025-03-31 0001829794 EMPD:ProductDevelopmentMember 2026-01-01 2026-03-31 0001829794 EMPD:ProductDevelopmentMember 2025-01-01 2025-03-31 0001829794 EMPD:GeneralAndAdministrativeMember 2026-01-01 2026-03-31 0001829794 EMPD:GeneralAndAdministrativeMember 2025-01-01 2025-03-31 0001829794 EMPD:DTCCMember 2026-01-01 2026-03-31 0001829794 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001829794 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001829794 us-gaap:StockOptionMember 2026-01-01 2026-03-31 0001829794 us-gaap:StockOptionMember 2025-01-01 2025-03-31 0001829794 2025-10-14 2025-10-15 iso4217:USD shares iso4217:USD shares pure EMPD:Integer false 2026 Q1 --12-31 0001829794

P10Y

P5Y

P10Y

10-Q true 2026-03-31 false 001-40867 Empery Digital Inc. DE 84-4882689 3121 Eagles Nest Street Suite 120 Round Rock TX 78665 512 400-4271 Common Stock EMPD NASDAQ Yes Yes Non-accelerated Filer true true false false 28110111

5702409

8963856

105000

2070558

2049413

2436983

78840

71869

63318

312106

396589

346175

2063494

2479310

12838351

14255860

129132431

126926895

74794125

230048488

280719 271560

99666

155056

673918

778235

217819210

372436094

3824669

745466

1391122

560761

728839 1189184

49890972

230309

322103

136882

76177

6311821

52784663

44952897

49945046

18326

20485

453322

471683

51736366

103221877

0.00001

5000000

100000

0.00001

250000000

29326650

33800951

535

475

24200757

13771094

140501869

96282082

708356659

681864757

-401772481

-316368933

166082844

269214217

217819210

372436094

225702

462332

162624

504592

63078

-42260

323636

296224

124946

234652

4571782

1549280

78354036

83374400

2080156

-83311322

-2122416

553429

54021

568142 -0 -62017 28432

42539

52771

2058035

89183

-2092226

46041

-85403548

-2076375

-0

-85403548

-2076375

-384055

-85403548

-2460430

-2.59

-6.13

-2.59

-6.13

-1.14

-2.59

-7.27

-2.59

-7.27

33022103

338235

33022103

338235

33800951

475

13771094

-96282082

681864757

-316368933

269214217

3396940 34 -3 31

212322

2558422 26 24787653 24787679

-10429663

10429663

-44219787

1704252

-85403548

29326650

535

24200757

-140501869

708356659

-401772481

166082844

78859

166357208

-166316447

40761

176116 2 -2

320867

220515 3 8846758 8846761

1296118

53750 1 10703881 10703882

10052

-47886

47886

-401806

-2460430

481354

47886

-401806

185917897

-168776877

16739220

-85403548

-2460430

78354036 0 -62017 28432 21145 -0

1704252

10052

11374

17992

68142 0

6970

16397

48737

104317

103855

14588

40754

2195165

32549

61788

-376290

-471206

449845

3079203

-163969

370016

-726467

-110155

-106502

-1545

-169034

-3498488

-3571888

23744

201841

74694788 0

74671044

-201841

50000000 -0

10000000

-0

212322

24787679 0 31 0 5000000 0

1296118

0 10703882

320867

8846761

1926

1719

44219787

401806

-74434003

19147118

-3261447

15373389

9068856

2298573

5807409

17671962

2008200

88208

3 14 0 59175 142699201 0 38529097 0 73686505 0 13032157 0

<p id="xdx_80C_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zZfHviSQdpeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE 1 – ORGANIZATION, NATURE OF OPERATIONS AND GOING CONCERN Organization and Nature of Operations Empery Digital Inc. (“Empery Digital” or the “Company”) was formed on February 21, 2020, as a Delaware corporation, under the name Frog ePowersports, Inc. The Company was renamed Volcon, Inc. on October 1, 2020. The Company was renamed Empery Digital Inc. on July 30, 2025, and changed its Nasdaq ticker symbol from VLCN to EMPD. On January 5, 2021, the Company created Volcon ePowersports, LLC (“Volcon LLC”), a Colorado wholly-owned subsidiary of the Company, to sell the Company’s vehicles and accessories in the United States (“U.S.”). Since 2023 Volcon LLC has not been used. Effective as of July 17, 2025, the Company adopted a digital asset treasury strategy with the goal of becoming a leading, low cost, capital efficient, globally trusted aggregator of Bitcoin (“BTC” or “Bitcoin”). Empery Digital Inc. was founded as the first all-electric powersports company sourcing high-quality and sustainable electric vehicles for the outdoor community. Going forward the Company intends to operate the powersports brand under the brand name Empery Mobility. As discussed in Note 13, on October 15, 2025, the Company entered into an asset purchase agreement with Venom EV, LLC (“Venom”) (the “Venom APA”), to divest the Volcon brand in exchange for a non-dilutable 10% equity position in Venom’s reorganized Delaware corporation on a fully-diluted basis. Going Concern The accompanying interim condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has recurring losses and has generated negative cash flows from operations since inception. As discussed in Notes 4, 5 and 9, the Company has raised proceeds to implement its digital asset treasury strategy including purchasing Bitcoin, repurchasing the Company’s common stock under the Company’s common stock repurchase program, repaying outstanding debt and funding operations. Management anticipates that our cash on hand as of March 31, 2026, plus cash expected to be generated from operations and premium from derivative trading, cash available from borrowings available on our credit facility and the cash received from the sale of Bitcoin will be sufficient to fund planned operations and to repay borrowings due beyond one year from the date of the issuance of the financial statements as of and for the three months ended March 31, 2026. Impact of Tariffs on Imported Goods from China and Vietnam On April 2, 2025, the U.S. imposed reciprocal tariffs on imports from various countries including China and Vietnam starting with a 10% baseline tariff. On April 9, 2025, China-specific tariffs increased significantly, while Vietnam’s tariffs were deferred for an initial 90-day period. That pause was later extended to August 1, 2025, and then to August 7, 2025, maintaining Vietnam’s tariff at the baseline 10% during such extension. Following ongoing negotiations, a tentative trade deal with Vietnam was reached on July 2, 2025. U.S. tariffs on Vietnamese goods would be set at 20%, while goods deemed to be Chinese in origin but routed through Vietnam (transshipments) would be subject to a 40% tariff. This replaces the originally stated 46% rate. The 20% rate became effective August 7, 2025. On July 31, 2025, the U.S. administration issued a formal Executive Order modifying the reciprocal tariff regime under the International Emergency Powers Act (“IEEPA”). For example, after announcing proposed blanket tariff rates of 46% on imports from Vietnam in April 2025, the U.S. and Vietnam governments announced a trade deal between the countries that imposes 20% tariffs on all products imported to the U.S. from Vietnam. The 20% rate became effective August 7, 2025, under the aforementioned Executive Order and is currently in force. China remains subject to an additional 30% tariff (down from the temporary increase, effective mid-May) under the continued reciprocal framework. That rate is in effect through August 12, 2025, pending further amendment. On August 11, 2025, the U.S. extended the existing tariff truce with China by 90 days to November 10, 2025, maintaining the 30% tariff rate during such extension. On February 20, 2026, the U.S. Supreme Court ruled that the IEEPA does not authorize the U.S. administration to impose tariffs. The tariffs paid by importers under the Executive order are subject to refund. The Company is currently following the process apply for a refund of amounts previously paid and will record such amounts, if any, when received. The U.S. administration has indicated that it intends to impose a 10% global tariff under Section 122 of the Trade Act of 1974. Tariffs imposed by the current U.S. administration continue to impact the Company’s cost for vehicles and parts manufactured in China. The Company remains actively evaluating strategic alternatives, including U.S. assembly or shifting production as well as potentially adjusting selling prices to offset elevated import costs.

0.10

0.46

0.20

0.46

0.20

0.10

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Interim Unaudited Financial Information The accompanying interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission (“SEC”) on March 27, 2026. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted from this report on Form 10-Q pursuant to the rules and regulations of the SEC. Results for the interim periods in this report are not necessarily indicative of future financial results and have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments necessary to present fairly our interim condensed consolidated financial statements as of March 31, 2026, and for the three months ended March 31, 2026 and 2025. These adjustments are of a normal recurring nature and are consistent with the adjustments recorded to prepare the annual audited consolidated financial statements as of December 31, 2025. Basis of Presentation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts, transactions and balances have been eliminated in consolidation. The Company completed a 1-for-8 reverse stock split on June 11, 2025. All share and per share amounts previously disclosed have been updated to reflect the impact of this reverse split. See Note 9 for further discussion. Per the terms of the 1-for-8 reverse stock split completed on November 8, 2024, the Company agreed that no fractional shares would be issued in connection with the reverse stock split and that it would issue one full share of the post-reverse stock split common stock to any stockholder who would have been entitled to receive a fractional share as a result of the process. On November 19, 2024, the Company received notice from DTCC on behalf of the brokerage firms that hold the shares of Company common stock held in “street name” that in connection with the foregoing rounding of shares the Company would need to issue <span id="xdx_90F_ecustom--CommonStockToBeIssuedForDisputedSharesFromNovember2024ReverseStockSplit_c20241118__20241119__srt--CounterpartyNameAxis__custom--DTCCStreetNameMember_zRmsw2xBFrMj" title="Number of shares to be issued">23,617 shares of common stock. The Company did not believe the number of shares being requested was correct based on the historical number of stockholders of its common stock and is aware of similar occurrences for other companies completing a reverse stock split. As such, the Company made inquiries into the calculations set forth in the request. The Company concluded that the information requested was not going to be provided and therefore on May 5, 2025, these shares were issued (see Note 11 for further discussion of impact to basic and diluted net loss per share). As discussed in further detail in Note 13, on October 15, 2025, the Company entered into the Venom APA with Venom to divest the Volcon brand other than the Brat in exchange for a non-dilutable 10% equity position in Venom’s reorganized Delaware corporation on a fully-diluted basis. The Company has reclassified all revenue and costs associated with the HF1 and MN1 products to loss from discontinued operations. Digital Assets The Company accounts for its digital assets, which are composed solely of Bitcoin, including Bitcoin restricted by lenders as collateral for borrowings, as non-current indefinite-lived intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other (“ASC 350”) and ASU 2023-08. The Company’s digital assets are initially recorded at cost and are measured at fair value as of each reporting period. The Company determines the fair value of its Bitcoin in accordance with ASC 820, Fair Value Measurement, based on quoted (unadjusted) prices on the Gemini exchange, the active exchange that the Company has determined is its principal market for Bitcoin (Level 1 inputs). Changes in fair value are recognized as incurred within “Loss on digital assets”, within operating expenses in the Company’s Condensed Consolidated Statement of Operations. Bitcoin restricted by lenders as collateral for borrowing are separately classified from digital assets due to the restrictions imposed on this Bitcoin until the underlying borrowings are repaid. Concentration Risk As of March 31, 2026, the Company holds $203.9 million of Bitcoin. See Note 4 for further discussion. The Company outsources certain portions of product design and development for its vehicles to third-parties. In addition, the Company has outsourced the manufacturing of all of its vehicles to third-party manufacturers. On December 6, 2024, the Company entered into a Settlement Agreement and Mutual Release (“Agreement”) with GLV, the manufacturer of the Stag and Grunt EVO, pursuant to which the Company and the manufacturer agreed to terminate the Supplier Agreement dated March 11, 2022 for the development and engineering of the Volcon Stag vehicle prototypes; the Supplier Agreement dated May 29, 2022 for the manufacturing of the Volcon Grunt EVO motorcycle; and the Supplier Agreement dated August 11, 2022 for the manufacturing of the Volcon Stag vehicle (collectively, the “Supplier Agreements”). Pursuant to the Agreement, among other items, the Company and the manufacturer agreed to indemnify each other with respect to certain outstanding vendor payables and the Company agreed to pay GLV a termination fee of $125,000 per month for a period of twenty-two months. The remaining payments for this agreement of $728,839 are classified as a short-term liability as they are due to be paid by September 2026. New Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

Basis of Presentation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts, transactions and balances have been eliminated in consolidation. The Company completed a 1-for-8 reverse stock split on June 11, 2025. All share and per share amounts previously disclosed have been updated to reflect the impact of this reverse split. See Note 9 for further discussion. Per the terms of the 1-for-8 reverse stock split completed on November 8, 2024, the Company agreed that no fractional shares would be issued in connection with the reverse stock split and that it would issue one full share of the post-reverse stock split common stock to any stockholder who would have been entitled to receive a fractional share as a result of the process. On November 19, 2024, the Company received notice from DTCC on behalf of the brokerage firms that hold the shares of Company common stock held in “street name” that in connection with the foregoing rounding of shares the Company would need to issue <span id="xdx_90F_ecustom--CommonStockToBeIssuedForDisputedSharesFromNovember2024ReverseStockSplit_c20241118__20241119__srt--CounterpartyNameAxis__custom--DTCCStreetNameMember_zRmsw2xBFrMj" title="Number of shares to be issued">23,617 shares of common stock. The Company did not believe the number of shares being requested was correct based on the historical number of stockholders of its common stock and is aware of similar occurrences for other companies completing a reverse stock split. As such, the Company made inquiries into the calculations set forth in the request. The Company concluded that the information requested was not going to be provided and therefore on May 5, 2025, these shares were issued (see Note 11 for further discussion of impact to basic and diluted net loss per share). As discussed in further detail in Note 13, on October 15, 2025, the Company entered into the Venom APA with Venom to divest the Volcon brand other than the Brat in exchange for a non-dilutable 10% equity position in Venom’s reorganized Delaware corporation on a fully-diluted basis. The Company has reclassified all revenue and costs associated with the HF1 and MN1 products to loss from discontinued operations.

1-for-8 reverse stock split

23617

Digital Assets The Company accounts for its digital assets, which are composed solely of Bitcoin, including Bitcoin restricted by lenders as collateral for borrowings, as non-current indefinite-lived intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other (“ASC 350”) and ASU 2023-08. The Company’s digital assets are initially recorded at cost and are measured at fair value as of each reporting period. The Company determines the fair value of its Bitcoin in accordance with ASC 820, Fair Value Measurement, based on quoted (unadjusted) prices on the Gemini exchange, the active exchange that the Company has determined is its principal market for Bitcoin (Level 1 inputs). Changes in fair value are recognized as incurred within “Loss on digital assets”, within operating expenses in the Company’s Condensed Consolidated Statement of Operations. Bitcoin restricted by lenders as collateral for borrowing are separately classified from digital assets due to the restrictions imposed on this Bitcoin until the underlying borrowings are repaid.

Concentration Risk As of March 31, 2026, the Company holds $203.9 million of Bitcoin. See Note 4 for further discussion. The Company outsources certain portions of product design and development for its vehicles to third-parties. In addition, the Company has outsourced the manufacturing of all of its vehicles to third-party manufacturers. On December 6, 2024, the Company entered into a Settlement Agreement and Mutual Release (“Agreement”) with GLV, the manufacturer of the Stag and Grunt EVO, pursuant to which the Company and the manufacturer agreed to terminate the Supplier Agreement dated March 11, 2022 for the development and engineering of the Volcon Stag vehicle prototypes; the Supplier Agreement dated May 29, 2022 for the manufacturing of the Volcon Grunt EVO motorcycle; and the Supplier Agreement dated August 11, 2022 for the manufacturing of the Volcon Stag vehicle (collectively, the “Supplier Agreements”). Pursuant to the Agreement, among other items, the Company and the manufacturer agreed to indemnify each other with respect to certain outstanding vendor payables and the Company agreed to pay GLV a termination fee of $125,000 per month for a period of twenty-two months. The remaining payments for this agreement of $728,839 are classified as a short-term liability as they are due to be paid by September 2026.

203900000

125000 728839

New Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

NOTE 3 – SEGMENT REPORTING In November 2023, the Financial Accounting Standards Board issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), requiring public companies to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public companies with a single report segment were required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements of ASU 2023-07 during the year ended December 31, 2024. Subsequent to the implementation of the Company’s digital asset treasury strategy, the Company continues to operate as one operating segment and the Company’s Co-CEOs are the chief operating decision makers (“CODMs”). The “Corporate & Other” category presented in the following tables is not considered an operating segment. It consists primarily of costs and expenses related to executing the Company’s Bitcoin strategy and includes the loss on digital assets, other third party costs associated with the Company’s Bitcoin holdings, and net interest expense primarily related to debt obligations, the net proceeds of which were primarily used to repurchase the Company’s common stock. Beginning in July 2025, the Company has dedicated certain corporate resources to its Bitcoin strategy. These costs, including related share-based compensation expense, are included within the “Corporate” and the “Share-based compensation expense” segment expense line items to better align with their activities and utilization. The following tables present (for the operating segment and the corporate & other category, and on a consolidated basis) the Company’s revenues and significant expenses regularly provided to the CODMs, reconciled to net income (loss) for each of the periods presented. <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z14KxHh1Xydi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of segment information</td><td> </td> <td colspan="2" id="xdx_499_20260101__20260331__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zbYvgn21atU9" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20260101__20260331__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateAndOtherMember_zKtBW4iny9Ig" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20260101__20260331_zhEfFcfBD5jd" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Three Months Ended March 31, 2026</td><td> </td> <td colspan="6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Segment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corporate & Other</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--Revenues_d0_zLyAovexDTh3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: justify">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">225,702</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">225,702</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di0_zdv4miHlZ3n6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Cost of goods sold</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(162,624</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(162,624</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--GrossProfit_pp0p0_d0_zrdeeyDgIDZ2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Gross margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,078</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,078</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--SellingAndMarketingExpense1_i01_pp0p0_d0_zma0zBXOvMj8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,636</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DevelopmentCosts_i01_pp0p0_d0_zRShBrSkNaV7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Product development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,946</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--GeneralAndAdministrativeExpense1_i01_pp0p0_d0_zbdVkUr8YCzb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,640,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,640,192</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--Corporate_i01_pp0p0_d0_zSceOOYM1vsc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Corporate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,217,772</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,217,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CustodyFees_i01_pp0p0_d0_zRWYZdcBHnHh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Digital asset custody fee</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,566</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,566</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_d0_zROZzG7Ll7w7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Share-based compensation expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,704,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,704,252</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--UnrealizedLossOnDigitalAssets_d0_z9kl7ML5M8o8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Loss on digital assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,354,036</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,354,036</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingExpenses_pp0p0_zzjqMgUg1jq8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,088,774</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">81,285,626</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">83,374,400</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherNoncashIncome_d0_zqzUC439P5M3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">553,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">553,429</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--LossOnRepaymentOfTermLoan_iN_di0_z2k3jgScAcR1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Loss on repayment of term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(568,142</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(568,142</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--LossOnChangeInFairValueOfFinancialLiabilities_d0_z5tD0mEma0ph" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Loss on change in fair value of financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,017</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,017</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--InterestIncomeOther_d0_zCxgo2TFYLj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Interest income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,539</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,539</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestExpenseNonoperating_iN_di0_z42t1emRFc0f" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Interest expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,035</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,035</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_pp0p0_zrU5ZGU6AUBl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,025,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(83,377,852</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(85,403,548</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> Prior to the implementation of the Company’s digital asset treasury strategy in July 2025, the Company operated as one operating segment, and the Company’s chief operating decision maker was the CEO, who used the consolidated statement of operations to assess financial performance. For the three month period ended March 31, 2025 see the condensed consolidated statement of operations above.

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z14KxHh1Xydi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of segment information</td><td> </td> <td colspan="2" id="xdx_499_20260101__20260331__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zbYvgn21atU9" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20260101__20260331__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateAndOtherMember_zKtBW4iny9Ig" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20260101__20260331_zhEfFcfBD5jd" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Three Months Ended March 31, 2026</td><td> </td> <td colspan="6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Segment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corporate & Other</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--Revenues_d0_zLyAovexDTh3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: justify">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">225,702</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">225,702</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di0_zdv4miHlZ3n6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Cost of goods sold</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(162,624</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(162,624</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--GrossProfit_pp0p0_d0_zrdeeyDgIDZ2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Gross margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,078</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,078</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--SellingAndMarketingExpense1_i01_pp0p0_d0_zma0zBXOvMj8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,636</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DevelopmentCosts_i01_pp0p0_d0_zRShBrSkNaV7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Product development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,946</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,946</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--GeneralAndAdministrativeExpense1_i01_pp0p0_d0_zbdVkUr8YCzb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,640,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,640,192</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--Corporate_i01_pp0p0_d0_zSceOOYM1vsc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Corporate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,217,772</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,217,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CustodyFees_i01_pp0p0_d0_zRWYZdcBHnHh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Digital asset custody fee</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,566</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,566</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_d0_zROZzG7Ll7w7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Share-based compensation expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,704,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,704,252</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--UnrealizedLossOnDigitalAssets_d0_z9kl7ML5M8o8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Loss on digital assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,354,036</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,354,036</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingExpenses_pp0p0_zzjqMgUg1jq8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,088,774</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">81,285,626</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">83,374,400</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherNoncashIncome_d0_zqzUC439P5M3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Other income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">553,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">553,429</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--LossOnRepaymentOfTermLoan_iN_di0_z2k3jgScAcR1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Loss on repayment of term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(568,142</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(568,142</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--LossOnChangeInFairValueOfFinancialLiabilities_d0_z5tD0mEma0ph" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Loss on change in fair value of financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,017</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,017</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--InterestIncomeOther_d0_zCxgo2TFYLj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Interest income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,539</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,539</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestExpenseNonoperating_iN_di0_z42t1emRFc0f" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Interest expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,035</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,058,035</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_pp0p0_zrU5ZGU6AUBl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,025,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(83,377,852</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(85,403,548</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

225702

162624

-0

162624

63078

323636 0 323636

124946

1640192 0 1640192 0 1217772 1217772

9566

1704252

0 78354036 78354036

2088774

81285626

83374400

553429

-0 568142 568142 0 -62017 -62017

42539

-0

2058035

-2025696

-83377852

-85403548

NOTE 4 – DIGITAL ASSETS As of March 31, 2026, the Company’s investment in digital assets comprises 2,989.4 Bitcoin, including 1,893.0 Bitcoin with a carrying value of $129,132,431 and 1,096.4 Bitcoin with a carrying value of $74,794,125 restricted by lenders as collateral for borrowing arrangements. Bitcoin restricted by lenders as collateral for borrowing arrangements will remain restricted until the underlying borrowings are repaid or until the value of such collateral increases to the Collateral Refund Level (as defined below) (see Note 5 for further discussion of the borrowing arrangements, collateral requirements, and repayment provisions). The following table summarizes the Company’s digital assets held as of March 31, 2026, and related activity for the three months ended March 31, 2026. <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zRwiCLM210yl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DIGITAL ASSETS (Details)"> <tr style="vertical-align: bottom"> <td id="xdx_8B8_zuWkDvIX04aa" style="display: none">Schedule of digital asset purchases</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Bitcoin at March 31, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">2,989.4</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Beginning balance – January 1, 2026</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--DigitalAssets_iS_d0_c20260101__20260331_zGes9Gj6miA5" style="text-align: right" title="Digital assets, beginning balance">356,975,383</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Bitcoin used to pay fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Bitcoin sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(74,694,788</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss on Bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(78,354,036</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Total Bitcoin carrying value at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">203,926,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less fair value of Bitcoin restricted by lenders as collateral for loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(74,794,125</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Digital assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--DigitalAssets_iE_c20260101__20260331_zBFeAtgIQJqj" style="border-bottom: Black 2.5pt double; text-align: right" title="Digital assets, ending balance">129,132,431</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the three months ended March 31, 2026, the Company sold 1,092 BTC for proceeds of $74,694,788 resulting in a realized loss of $53,260,259 based on the original cost of the BTC sold. BTC is a digital asset, which is a novel asset class that is subject to significant legal, commercial, regulatory and technical uncertainty. Holding BTC does not generate any cash flows and involves custodial fees and other costs. Additionally, the price of BTC has historically experienced significant price volatility, and a significant decrease in the price of BTC would adversely affect the Company’s financial condition and results of operations. The Company’s strategy of acquiring and holding BTC also exposes it to counterparty risks with respect to the custody of its BTC, cybersecurity risks, and other risks inherent to holding a digital asset. In particular, the Company is subject to the risk that, if its private keys with respect to its digital assets are lost or destroyed or other similar circumstances or events occur, the Company may lose some or all of its digital assets, which could materially adversely affect the Company’s financial condition and results of operations. To mitigate this risk, the Company utilizes multiple custodians in order to limit the concentration of holding its digital assets within one custodian. The Company from time to time also enters into short-term put and call contracts for Bitcoin to generate income on its Bitcoin holdings. As of March 31, 2026, there were no such outstanding contracts. During the three months ended March 31, 2026, the Company generated income of $548,301 from trading these put and call contracts, which is recorded in other income in the condensed consolidated statement of operations. In the period from April 1, 2026 to May 7, 2026, the Company sold 75 BTC and received proceeds of $5,369,291. As discussed in Note 5, during this period the Company also borrowed proceeds of $10.0 million and transferred 257 BTC as collateral for the additional borrowing.

129132431 1096 74794125

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zRwiCLM210yl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DIGITAL ASSETS (Details)"> <tr style="vertical-align: bottom"> <td id="xdx_8B8_zuWkDvIX04aa" style="display: none">Schedule of digital asset purchases</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Bitcoin at March 31, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">2,989.4</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Beginning balance – January 1, 2026</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--DigitalAssets_iS_d0_c20260101__20260331_zGes9Gj6miA5" style="text-align: right" title="Digital assets, beginning balance">356,975,383</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Bitcoin used to pay fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Bitcoin sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(74,694,788</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss on Bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(78,354,036</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Total Bitcoin carrying value at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">203,926,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less fair value of Bitcoin restricted by lenders as collateral for loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(74,794,125</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Digital assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--DigitalAssets_iE_c20260101__20260331_zBFeAtgIQJqj" style="border-bottom: Black 2.5pt double; text-align: right" title="Digital assets, ending balance">129,132,431</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2989 356975383 -3 -74694788 -78354036 203926556 -74794125 129132431 NOTE 5 – BORROWINGS FOR SHARE REPURCHASES Credit Facility and Term Loan On August 15, 2025, the Company entered into a Master Repurchase Agreement and related commitment letter (together the “MRA”) with a third-party pursuant to which the Company could borrow up to $25.0 million. Upon entry into the MRA the Company paid a commitment fee of $150,000 in connection with the MRA, which the Company had recorded as loan issuances costs and amortized this amount, plus legal fees associated with the MRA, over the 90 day term of the borrowings. Upon the initial borrowing date, the Company was required to place a minimum of $15,625,000 of BTC in a custody account with an affiliate of the third-party, which was required to be retained through the term of the agreement. The interest on all borrowings under the MRA was <span id="xdx_902_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20250814__20250815__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zaxsXF2Z6JCc" title="Borrowings interest rate">11.0% per annum, which was payable monthly. On September 18, 2025, the Company and the third-party lender amended the MRA and increased the available borrowings by an additional $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityIncreaseDecreaseForPeriodNet_pn6n6_c20250917__20250918__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zPjKcPzpOv79" title="Additional borrowing">10.0 million which also required the Company to increase the amount of Bitcoin in the custody account to a total of $21,875,000. All other provisions of the MRA remained the same. The Company borrowed the full $<span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn6n6_c20250921__20250922__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_z5IMgyIuyzn2" title="Maximum borrowed during period">35.0 million available under the MRA, as amended, as of September 22, 2025, and used the proceeds to repurchase its common stock, including any brokerage commissions under the Company’s common stock repurchase program. On September 26, 2025, the Company and the third-party lender under the MRA entered into a new Master Repurchase Agreement and related transaction confirmation (together the “Repo Facility”) with a maturity date of August 31, 2026 and providing for $<span id="xdx_905_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn6n6_c20250926__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zINp5yDYgeIk" title="Cash advances">50.0 million in cash advances to the Company in exchange for purchased securities in the form of Bitcoin. Upon entry into the Repo Facility, the Company paid a commitment fee of $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zNdMR9qzZFRc" title="Loan issuance costs">125,000, which was recorded as loan issuance costs which, with legal fees incurred for the Repo Facility, were being amortized through August 31, 2026, the due date for any outstanding borrowings. The interest rate for borrowings under the Repo Facility is <span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20250925__20250926__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zAArZgNCnBXi" title="Borrowings interest rate">8.5% per annum. The first $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn6n6_c20250921__20250922__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_z2nolzpHaW74" title="Maximum borrowed during period">35.0 million borrowed under the Repo Facility was used to repay all outstanding borrowings under the MRA and there was no early prepayment penalty. In addition, borrowings under the Repo Facility were used to pay accrued interest for borrowings outstanding under the MRA of $<span id="xdx_903_eus-gaap--LineOfCreditFacilityIncreaseAccruedInterest_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_z5McaSJXUG3j" title="Accrued interest paid">165,917, and the $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_c20250925__20250926__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zq1ATZyKLvl5" title="Commitment fee">125,000 commitment fee. The remaining proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromLinesOfCredit_pn5n6_c20250925__20250926__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zQITuAHvQSy5" title="Proceeds from line of credit">14.7 million were deposited into one of the Company’s bank accounts and the Company used the proceeds to repurchase its common stock, including commissions due to the placement agent, under the Company’s common stock repurchase program, as discussed further in Note 9 below. <span id="xdx_90D_ecustom--LineOfCreditFacilityDescription2_c20250925__20250926__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zcHBHBOqfFAb" title="Line of credit facility, description">The Repo Facility has an early prepayment fee of 2% if repaid within six months of the agreement date and 1% if paid after six months but before August 31, 2026. The Company recognized a loss on the repayment of the MRA totaling $<span id="xdx_909_ecustom--LossOnRepaymentOfCreditFacility_pp0p0_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zt7ZowdJvFv" title="Recognized loss on unamortized issuance costs">125,377 for the unamortized issuance costs, which includes the commitment fee and legal fees, as of the repayment date. On March 31, 2026 the Company repaid the outstanding balance under the Repo Facility in full, including interest through the repayment date, which terminated the MRA. The Company recognized a loss on the repayment of the Repo Facility totaling $<span id="xdx_904_ecustom--LossOnRepaymentOfCreditFacility_pp0p0_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zSSz6iViImGg" title="Recognized loss on unamortized issuance costs">568,142 for the unamortized issuance costs as of the repayment date, and the <span id="xdx_90C_ecustom--LineOfCreditFacilityPrepaidInterestRateDuringPeriod_dp_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--RepoFacilityMasterRepurchaseAgreementMember_zDA8Qm5QkRJb" title="Prepaid interest rate">1% prepayment fee paid. Upon repayment the lender released 1,795 Bitcoin which was held as collateral for the Repo Facility. For the three months ended March 31, 2026, the Company recognized $1,050,695 of interest expense for the Repo Facility. Delayed Draw Term Loans On October 12, 2025, the Company entered into a Master Loan Agreement (the “MLA”) with a lender to obtain additional capital in the form of delayed draw term loans. Under the MLA, the Company may borrow, an aggregate principal amount of up to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20251012__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zlPi61zaDgOa" title="Principal amount">100.0 million, through October 9, 2026 (subject to the extension referenced below), at which date, all such loans, together with any accrued and unpaid interest and related obligations, shall become due and payable in their entirety. The Company had the option, in its sole discretion, to extend the due date of all such loans for one additional year, to October 9, 2027 and the Company exercised this option on October 29, 2025. Further, the MLA was not subject to any commitment fees and borrowings can be repaid early without any prepayment penalty or premium. Prior to the amendment discussed below, the interest rate applicable to all outstanding loans was <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251012__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zkmVNUyhsmt1" title="Percentage of annum payable monthly">6.50% per annum payable monthly. The MLA initially required the Company to provide the Lender collateral of BTC equal to 250% of any amount borrowed (the “Initial Collateral Rate”). If the value of BTC held by the lender as collateral decreased below 175% of the aggregate borrowings outstanding (“Collateral Call Level”), the Company is required to provide additional BTC to increase the value back to 250% of the aggregate borrowings outstanding. If the value of BTC increased to over 345% of the total aggregate outstanding borrowings (the “Collateral Refund Level”), the lender is required to return BTC to the Company until the collateral equals 250% of the aggregate outstanding borrowings. If the value of BTC decreased below 150% of the aggregate borrowings outstanding (the “Liquidation Level”) the Company was required to provide additional BTC to increase the value back to 250% within 24 hours or the lender may liquidate collateral equal to the amount to repay the aggregate outstanding borrowings and return any remaining collateral to the Company. On February 4, 2026, the value of BTC decreased below the Collateral Call Level and the Company provided the lender 576 BTC to bring the value of the collateral back to the Initial Collateral Level. On February 10, 2026, the MLA was amended and the Initial Collateral Rate was reduced to 174%, the Collateral Call Level was reduced to 153%, the Collateral Refund Level was reduced to 217% and the Liquidation Level was reduced to 143%. The lender returned 490 BTC to the Company as a result of this amendment. The amendment also increased the interest rate applicable to all outstanding loans to 7.5% and reduced the time period for the Company to provide collateral for the Liquidation Level to 12 hours. During the three months ended March 31, 2026, the Company borrowed $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20260331__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zei0TCMzIEgj" title="Principal amount">5 million and repaid $<span id="xdx_905_eus-gaap--DebtInstrumentRepurchaseAmount_iI_pn6n6_c20260331__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zM4XY9C5ffbj" title="Repaid amount">10 million. As of March 31,2026, the Company has borrowings outstanding under the MLA totaling $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_pn6n6_c20260331__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zypoGGPVrCA" title="Outstanding balance">45.0 million and provided 1,096 BTC with a fair value of $<span id="xdx_905_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20260331__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zLu2NQQretR6" title="Fair value">74,794,125 to the MLA lender as collateral. For the three months ended March 31, 2026, the Company recognized $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pp0p0_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zL635V5ES2Ch" title="Interest expense">929,028 of interest expense. In the period from April 1, 2026 to May 7, 2026, the Company borrowed an additional $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20260507__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermLoansMember__us-gaap--TransactionTypeAxis__custom--MasterRepurchaseAgreementMember_zxdgUqhES7H8" title="Principal amount">10.0 million under the MLA.

25000000

150000

Upon the initial borrowing date, the Company was required to place a minimum of $15,625,000 of BTC in a custody account with an affiliate of the third-party, which was required to be retained through the term of the agreement.

0.110

10000000

which also required the Company to increase the amount of Bitcoin in the custody account to a total of $21,875,000. All other provisions of the MRA remained the same.

35000000

50000000

125000

0.085

35000000

165917

125000

14700000

The Repo Facility has an early prepayment fee of 2% if repaid within six months of the agreement date and 1% if paid after six months but before August 31, 2026. 125377 568142 0.01

1050695

100000000.0

0.0650

576

5000000

10000000

45000000

74794125

929028

10000000

NOTE 6 – NOTE PAYABLE In March 2023, the Company entered into a financing arrangement to purchase a vehicle with an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230301__20230331__us-gaap--TypeOfArrangementAxis__custom--FinancingArrangementMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember__srt--RangeAxis__srt--MaximumMember_zGTM12F24VX2" title="Interest rate">11.44% and a monthly payment of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230301__20230331__us-gaap--TypeOfArrangementAxis__custom--FinancingArrangementMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zBqg955YsWm6" title="Monthly payments">908 until February 2029. The vehicle is collateral for this arrangement. The short-term balance of $<span id="xdx_904_eus-gaap--ShortTermBorrowings_iI_pp0p0_c20260331__us-gaap--TypeOfArrangementAxis__custom--FinancingArrangementMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zk4JL9RcNbo9" title="Short term balance">8,280 as of March 31, 2026 is presented in other current liabilities in the condensed consolidated balance sheet. In April 2026, the loan balance was fully paid.

0.1144

908

8280

NOTE 7 – WARRANT LIABILITIES Series A Warrants The Company issued Series A warrants (the “Series A Warrants”) in connection with the sale of common units and pre-funded warrant units. Under the terms of the Series A Warrants, the number and exercise price are subject to adjustment if the Company completes certain transactions specified in applicable warrant agreements. In addition, the Series A Warrants have a cashless exercise provision, which would allow holders to cashless exercise one warrant for three shares of the Company’s common stock. Such adjustment provisions of the Series A Warrants were initially subject to stockholder approval, which was received on January 12, 2024. The Company initially determined that these warrants should be classified as liabilities and used a Monte Carlo simulation to estimate the fair value until stockholder approval of the cashless exercise provision was completed. Subsequent to the approval by stockholders of the cashless exercise provision of the Series A Warrant, the fair value of each Series A Warrant is the value of three shares of the Company’s common stock. Based on the closing price of the Company’s common stock on March 31, 2026 of $4.23, the fair value of each Series A Warrant is $12.69 and based on the total number of warrants outstanding of 10,008, the warrant liability for Series A Warrants is $127,002 at March 31, 2026. The following represents the activity associated with the Series A Warrants for the three months ended March 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeInstrumentsIncludedInTradingActivitiesTextBlock_zgjYGeLr6gO8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT LIABILITIES (Details - Activity associated with warrants)"> <tr style="vertical-align: bottom"> <td>Schedule of derivative liability</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Fair value on January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeFairValueOfDerivativeLiability_iS_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zJJFfY3IX2p2" style="width: 13%; text-align: right" title="Fair value, beginning balance">64,985</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss on change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--GainOnChangesInFairValue_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zEHVg2G8W5cj" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on changes in fair value">62,017</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeFairValueOfDerivativeLiability_iE_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zmgadP1ANSCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value, ending balance">127,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The balance is classified in other current liabilities in the condensed consolidated balance sheet.

4.23

12.69

10008

127002

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeInstrumentsIncludedInTradingActivitiesTextBlock_zgjYGeLr6gO8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANT LIABILITIES (Details - Activity associated with warrants)"> <tr style="vertical-align: bottom"> <td>Schedule of derivative liability</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Fair value on January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeFairValueOfDerivativeLiability_iS_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zJJFfY3IX2p2" style="width: 13%; text-align: right" title="Fair value, beginning balance">64,985</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss on change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--GainOnChangesInFairValue_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zEHVg2G8W5cj" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on changes in fair value">62,017</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeFairValueOfDerivativeLiability_iE_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zmgadP1ANSCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value, ending balance">127,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

64985

62017

127002

NOTE 8 – RELATED PARTY TRANSACTIONS Gemini On July 13, 2025, the Company entered into a Strategic Digital Assets Services Agreement with Gemini NuStar, LLC (“Gemini”) (the “Gemini Agreement”), pursuant to which Gemini will provide non-discretionary execution and digital asset-related informational services. These services may include market commentary, protocol updates, or other general insights as directed by the Company. Gemini does not act as an advisor, fiduciary, or investment manager to the Company, and all trading and investment decisions remain solely under the Company’s control. In connection with the Gemini Agreement, upon the closing of the Private Placement, the Company issued a warrant to Gemini to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250713__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember__dei--LegalEntityAxis__custom--GeminiNuStarLLCMember_zoRSjE2Xwzj7" title="Warrants issued">901,542 shares of common stock, discussed further in Note 9. Also on July 13, 2025, the Company entered into a Custodial Services Agreement (together with the Gemini Agreement, the “Gemini Agreements”) with Gemini Trust Company, LLC (“Gemini Trust”), pursuant to which the Company has engaged Gemini Trust to provide custody services of the Company’s digital asset holdings. The Company pays a monthly custodial fee as a percentage of the digital assets held in the Company’s custodial accounts at Gemini at month end. For the three months ended March 31, 2026, the Company has recognized no custodial fee expense. Mr. Rohan Chauhan, a member of the Company’s board of directors (the “Board”), was the Director of Strategy at Gemini until December 23, 2025. Board of Directors On July 17, 2025, in connection with the Private Placements, the Company’s four existing independent members of the Board prior to the Private Placements received an aggregate payment from the Company of $<span id="xdx_907_ecustom--PaymentForEquityAwards_c20250715__20250717__srt--CounterpartyNameAxis__custom--FourBoardMembersMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zSXZVmk56eO5" title="Payment for equity awards">600,000 in cash, with each individual amount based on their board tenure as payment for equity awards that could not be issued previously as part of their compensation for being on the Company’s Board. Each existing independent director also received a grant of 10,000 stock options from the Company’s 2025 Stock Plan to purchase the Company’s common stock at $10 per share with a ten-year term, regardless of service being provided and only forfeitable in the event Board service is terminated for cause as defined in the stock option agreements (the “Forfeiture Clause”). These stock options vest in 20% installments based upon the achievement of milestones tied to the daily VWAP of the Company’s common stock trading price with the first 20% vesting at $10.00 and each installment increasing in $5.00 increments, and all stock options fully vesting if the daily VWAP reaches $30.00 (the “Applicable Vesting Schedule”). Pursuant to the Applicable Vesting Schedule, 80% of these options had vested as of March 31, 2026. These stock options are not exercisable until the 2025 Stock Plan and shares to be issued under the 2025 Stock Plan are approved by the Company’s stockholders (the “Approval Requirement”). These Board members collectively purchased <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250715__20250717__srt--CounterpartyNameAxis__custom--FourBoardMembersMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zfpsJkEcIzN5" title="Stock issued new, shares">60,000 shares of the Company’s common stock for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250715__20250717__srt--CounterpartyNameAxis__custom--FourBoardMembersMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zzvLvyjuznYl" title="Stock issued new, value">600,000 in the Private Placements. In connection with the Private Placements, the Board elected Ryan Lane, Ian Read, Rohan Chauhan and Matthew Homer to serve on the Board until director elections are held at the Company’s next stockholder meeting. In connection with the appointment of each of Messrs. Read, Homer and Chauhan as directors, each: (a) signed an offer letter with the Company pursuant to which they each will be entitled to an annual fee of $<span id="xdx_903_eus-gaap--NoninterestExpenseDirectorsFees_c20250715__20250717__srt--CounterpartyNameAxis__custom--ReadHomerAndChauhanMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zyQpYb47LPWf" title="Director fees">40,000 plus a $<span id="xdx_907_ecustom--NoninterestExpenseDirectorsFeesAddition_c20250715__20250717__srt--CounterpartyNameAxis__custom--ReadHomerAndChauhanMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zxpZEktxSNn1" title="Director fees, additional">10,000 fee for any committees on which they serve, both of which will be paid quarterly; and (b) was granted <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250715__20250717__srt--CounterpartyNameAxis__custom--ReadHomerAndChauhanMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_z6tDZxZ9EQF" title="Options granted">298,802 stock options from the Company’s 2025 Stock Plan to purchase the Company’s common stock at $10.00 per share with a ten-year term, and subject to the Forfeiture Clause. These stock options vest in accordance with the Applicable Vesting Schedule and are subject to the Approval Requirement. In connection with the Private Placements, Mr. Lane was also appointed to serve as both Chairman of the Board and Co-Chief Executive Officer (“Co-CEO”) of the Company. Mr. Lane signed an employment agreement with the Company, dated July 17, 2025, and his annual salary is $225,000. Mr. Lane was also paid a signing bonus of $225,000 and was granted <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLaneMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member_zYywXxIJcYe1" title="Options granted">1,792,812 stock options from the Company’s 2025 Stock Plan to purchase the Company’s common stock at $10.00 per share with a <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLaneMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member_zeR2Hm3kYdGk" title="Term::XDX::P10Y">ten-year term, and subject to the Forfeiture Clause. These stock options vest in accordance with the Applicable Vesting Schedule and are subject to the Approval Requirement. Mr. Lane is a founder and principal of Empery Asset Management LP (“EAM”), an investor in the Company, and will continue to provide services to EAM while also being employed by the Company. Mr. Lane also purchased <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLaneMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zb4wSXtxtYLk">100,000 shares of the Company’s common stock for $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLaneMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zrWqw8yXApQb" title="Proceeds from sale of stock">1.0 million and funds controlled by EAM purchased <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zvCfegifMMjk">2,500,000 shares of the Company’s common stock for $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20250715__20250717__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementsMember_zL9rKeqnAZPg" title="Proceeds from sale of stock">25.0 million in the Private Placements. As of March 31, 2026, funds controlled by EAM own 2,930,345 shares of the Company’s common stock, and the following warrants to purchase the Company’s common stock i) <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrants01Member_zhi6rOhV0vf5" title="Warrants outstanding">4,323 pre-funded warrants with an exercise price of $0.00001, ii) <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrants08Member_zDMzzkeBTmx2" title="Warrants outstanding">340,626 pre-funded warrants with an exercise price of $0.00008, iii) <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrants16Member_zlMKJfi4ssfi" title="Warrants outstanding">493,751 warrants with an exercise price of $16.00, iv) <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EAMMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrants1856Member_zXA9S0S5HxR2" title="Warrants outstanding">804 warrants with an exercise price of $1,856.00. All Board members, other than Mr. Lane and Mr. John Kim, also Co-CEO and director, receive an annual fee of $40,000 payable quarterly plus an additional fee of $<span id="xdx_904_eus-gaap--NoninterestExpenseDirectorsFees_c20250715__20250717__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--NatureOfExpenseAxis__custom--CommitteeFeesMember_zi8S9G9gmvhg" title="Committees fee">10,000 for each committee of the Board on which each director serves, if any. In March 2025, the Company entered into a consulting agreement with ThankYou Studios, an entity owned by Orn Olason, a member of the Company’s Board. ThankYou Studios completed a marketing and brand assessment for the Company and the total fees were $45,000. Existing Officers Chief Executive Officer On January 30, 2024, John Kim, formerly an independent Board member of the Company, signed an employment agreement with the Company to become the CEO effective February 3, 2024. Mr. Kim’s salary was $800,000 and he had an annual bonus of $250,000. Mr. Kim would also receive 5% of the gross proceeds or other consideration if the Company completes a sale of substantially all of its assets or otherwise enters into a change of control transaction. Mr. Kim would also be entitled to an equity award equal to 10% of the Company’s fully diluted equity, subject to stockholder approval. The Company’s stockholders approved stock options to purchase 180,375 shares of the Company’s common stock at $4.56 per share at the annual stockholders’ meeting held on May 30, 2025. These stock options are fully vested and expire on May 30, 2035. The above employment agreement was terminated upon execution of a new employment agreement in conjunction with the Private Placements, following which Mr. Kim became Co-CEO and remained on the Board. His annual salary under the new employment agreement is $<span id="xdx_903_eus-gaap--OfficersCompensation_pp0p0_c20240129__20240130__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_z6C2KubvUBIe" title="Annual salary">225,000 and he received a bonus of $<span id="xdx_900_ecustom--AnnualBonus_iI_c20240130__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zxYLrSwXcE03" title="Annual bonus">225,000 payable upon signing of the new employment agreement with no further bonuses due to Mr. Kim. Mr. Kim was granted <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zlEtzUCmx16g" title="Shares granted">1,494,010 stock options from the Company’s 2025 Stock Plan to purchase the Company’s common stock at $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zjIdeEc13oda" title="Share price">10.00 per share with a ten-year term, and subject to the Forfeiture Clause. These stock options vest in accordance with the Applicable Vesting Schedule and are subject to the Approval Requirement. Mr. Kim also agreed to modify his previously granted stock options in May 2025 to increase the exercise price from $<span id="xdx_909_eus-gaap--StockOptionExercisePriceIncrease_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zOe8bUTt8dPj" title="Stock option exercise price">4.56 to $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_z1ydVycgYShj" title="Share price">10.00 per share upon completion of the Private Placements. Mr. Kim also purchased <span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_znco86sRHvc" title="Number of shares purchased">22,500 shares of the Company’s common stock for $<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrKimMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zfUZBIa4JETa" title="Number of shares purchased, value">225,000 in the Private Placements. Chief Financial Officer On January 30, 2024, Greg Endo, the Company’s Chief Financial Officer, signed a new employment agreement with the Company. Mr. Endo’s salary was increased to $300,000 and he would have an annual bonus of up to 50% of his salary as determined by the compensation committee of the Board. The Board approved the full amount of Mr. Endo’s 2024 bonus. Mr. Endo would also receive 5% of the gross proceeds or other consideration if the Company completes a sale of substantially all of its assets or otherwise enters into a change of control transaction. Mr. Endo would also be entitled to an equity award equal to 4% of the Company’s fully diluted equity, subject to stockholder approval. The Company’s stockholders approved a grant to Mr. Endo of stock options to purchase 72,150 shares of the Company’s common stock at $4.56 per share at the annual stockholders’ meeting held on May 30, 2025. These stock options are fully vested and expire on May 30, 2035. The above employment agreement was terminated upon execution of a new employment agreement in conjunction with the Private Placements. Mr. Endo remains as the Company’s Chief Financial Officer and his annual salary under the new employment agreement is $<span id="xdx_900_eus-gaap--OfficersCompensation_pp0p0_c20240129__20240130__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_z596a4CNMZ1h" title="Annual salary">300,000 and he received a bonus of $<span id="xdx_901_ecustom--AnnualBonus_iI_c20240130__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zz6DQCjkYhY" title="Annual bonus">150,000 payable upon signing of the new employment agreement with no further bonuses due to Mr. Endo. Mr. Endo was granted <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_ziycB8DFAHMf" title="Shares granted">747,005 stock options from the Company’s 2025 Stock Plan to purchase the Company’s common stock at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zZav5lvplVw3" title="Share price">10.00 per share with a <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_z3OsTfjBYTLd" title="Term::XDX::P10Y">ten-year term, and subject to the Forfeiture Clause. These stock options vest in accordance with the Applicable Vesting Schedule and are subject to the Approval Requirement. Mr. Endo also agreed to modify his previously granted stock options to increase the exercise price from $<span id="xdx_905_eus-gaap--StockOptionExercisePriceIncrease_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zTN9Up4kSyp7" title="Stock option exercise price">4.56 to $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zj6epJ2wIPp8" title="Share price">10.00 per share upon completion of the Private Placements. Mr. Endo also purchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_zen7iyhdX1Ub" title="Number of shares purchased">20,000 shares of the Company’s common stock for $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_c20240129__20240130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEndoMember__us-gaap--PlanNameAxis__custom--StockPlan2025Member__us-gaap--TransactionTypeAxis__custom--NewEmploymentAgreementMember_z2BQpMFAcWQf" title="Number of shares purchased, value">200,000 in the Private Placements. The Company accrued the above-mentioned bonuses payable to Mr. Kim and Mr. Endo under their employment agreements prior to the Private Placements in accrued liabilities as of December 31, 2024, and these were paid in April 2025. The bonuses payable upon signing of the new employment agreements were paid in July 2025. Other Executive Officer Appointments In connection with the Private Placements, the Board appointed Timothy Silver and Brett Director to serve on the Company’s management team. Mr. Silver serves as Chief Operating Officer and Mr. Director serves as Vice President of Legal. Mr. Silver and Mr. Director signed employment agreements, and their annual salaries are $150,000 and $200,000, respectively. Mr. Silver and Mr. Director were also granted <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrSilverMember_zTgDdu1L4hH5" title="Shares granted">597,604 and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrDirectorMember_z0eEGYviRzzi" title="Shares granted">298,802 inducement stock options, respectively, to purchase the Company’s common stock at $10.00 per share with a <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrSilverMember_z70F68nRAx15" title="Term::XDX::P10Y"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrDirectorMember_zq2vFQihVRq2" title="Term::XDX::P10Y">ten-year term, subject to the Forfeiture Clause. These stock options vest in accordance with the Applicable Vesting Schedule. Mr. Silver and Mr. Director are also employees of EAM and will continue to provide services to EAM while also being employees of the Company. Mr. Silver purchased <span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrSilverMember_zLnnh7sZxmpe" title="Number of shares purchased">2,500 shares of the Company’s common stock for $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrSilverMember_zduagSRSPXNb" title="Number of shares purchased, value">25,000 and Mr. Director purchased 10,000 shares of the Company’s common stock for $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrDirectorMember_ztQxmny2CaG5" title="Number of shares purchased, value">100,000 in the Private Placements. Highbridge Consultants, LLC On August 28, 2020, the Company entered into a consulting agreement (as amended on or about March 25, 2021) (the “Highbridge Consulting Agreement”) with Highbridge Consultants, LLC (“Highbridge”), an entity controlled by Mr. Adrian James, a co-founder of the Company, pursuant to which Mr. James provided the Company with services in exchange for warrants. The Highbridge warrants were fully exercised on a cashless basis in 2021. In addition, pursuant to the Highbridge Consulting Agreement, upon the occurrence of a Fundamental Transaction (as defined), Mr. James would have been eligible for additional compensation based on specified market capitalization thresholds. On July 11, 2025, the Company entered into a release and termination agreement (the “Consultant Termination Agreement”) with Highbridge pursuant to which the parties agreed to terminate and mutually release all of the parties’ rights and obligations under the Highbridge Consulting Agreement, including the release of the Company’s obligation to make certain market capitalization milestone payments to Highbridge, in exchange for the payment by the Company of a termination fee in an aggregate amount of $2.0 million, which was paid and expensed in the year ended December 31, 2025. New York Office Lease On August 28, 2025, the Company entered into an assignment and assumption of a lease agreement with EAM whereby the Company agreed to assume half of the lease obligation of the New York City office lease of EAM since three of EAM’s executives and one additional employee became Company employees in conjunction with the Private Placement as these individuals will continue to work in the New York City office. The Company, EAM and the landlord for the facility entered into a Consent to Assignment Agreement whereby the Company and EAM are jointly and severally liable for payment of the rent to the landlord. In the event that either EAM or the Company do not make their respective payments, then the other entity will be liable for the full rent payment to the landlord and the paying entity can seek recourse from the non-paying entity under the contribution agreement between them. The Company’s portion of its lease obligation to the landlord is $9,617 per month through June 2029, subject to adjustment for changes in property taxes assessed to the landlord on the facility. EAM signed an extension with the landlord of the lease beyond June 2029. The Company will have the option to opt out of this lease extension by providing EAM notice on or prior to June 1, 2029.

901542

600000

60000

600000

40000

10000

298802

225000

1792812

100000

1000000

2500000

25000000

2930345

4323

340626

493751

804

40000

10000

45000

800000

250000

225000

1494010

10.00

4.56

10.00

22500

225000

300000

annual bonus of up to 50% of his salary as determined by the compensation committee of the Board. The Board approved the full amount of Mr. Endo’s 2024 bonus.

300000

150000

747005

10.00

4.56

10.00

20000

200000

150000

200000

597604

298802

10.00

2500

25000

100000

2000000

9617

NOTE 9 – STOCKHOLDERS’ EQUITY The Company is authorized to issue 250,000,000 shares of common stock and 5,000,000 shares of preferred stock both with a par value of $0.00001. The specific rights of the preferred stock, when so designated, shall be determined by the Board. On June 11, 2025, the Company completed a 1-for-8 reverse stock split. Any stockholders with fractional shares as a result of the reverse stock split were paid cash (without interest) equal to such fractional shares multiplied by the average closing sales prices of the Company’s common stock during regular trading hours for the five consecutive trading days immediately preceding the reverse stock split. A total of $941 was paid for the satisfaction of fractional shares. Common Stock March 2026 Offering On March 24, 2026, the Company consummated a registered direct offering pursuant to which it received net proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember_ztihdIEeCpP8">24,787,679 from the sale of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember_zxZuuil0jcT4">2,558,422 common stock units, which consisted of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zJwaA561rOnb">2,558,422 shares of common stock and <span id="xdx_90C_ecustom--WarrantsIssued_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zCCWRwuqsE06">2,558,422 fully exercisable four-year warrants to purchase the Company’s common stock at $6.27 per share (the “March 2026 Warrants”), and <span id="xdx_90C_ecustom--PrefundedWarrantsIssued_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_zgR7GiLyY4Xi">2,079,797 pre-funded warrant units, which consisted of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_z01XFzimAfO3">2,079,797 pre-funded fully exercisable warrants with an exercise price of $0.00001 and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_z5rysgsggKu4">2,079,797 March 2026 Warrants. Through March 31, 2026, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pp0p0_c20260323__20260324__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_zbYYsA70Clkl">100,000 pre-funded warrants were exercised and for the period from April 1, 2026 to May 7, 2026, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260401__20260507__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--March2026OfferingMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAo3ZOD6rIdg">892,709 pre-funded warrants were exercised. No March 2026 Warrants have been exercised through May 7, 2026. July 2025 Private Placements On July 17, 2025, the Company entered into (i) a securities purchase agreement (the “Cash Purchase Agreement”), and (ii) a securities purchase agreement, (the “BTC Purchase Agreement” and, together with the Cash Purchase Agreement, the “Purchase Agreements”) by and among the Company and each purchaser party thereto pursuant to which the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250716__20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember_zIHkev3zNw93" title="Stock issued new, shares">44,414,189 shares of common stock of the Company, par value $0.00001 per share and pre-funded warrants to purchase up to an aggregate of <span id="xdx_90B_ecustom--WarrantsIssuedShares_c20250716__20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantsMember_zmX69cTkq9Ya" title="Warrants issued, shares">5,728,662 shares of common stock. The Company received aggregate gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn6n6_c20250716__20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember_zVu5NrIhanC2" title="Gross proceeds private placement">501.0 million, before deducting cash expenses including placement agent fees and other transaction related expenses of approximately $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_pn6n6_c20250716__20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember_zwTkUuFIHRI7" title="Payments of stock issuance costs">21.0 million, which excludes the value of the warrants issued to the placement agents as discussed below. Gross proceeds included payment of 235.8 BTC pursuant to the BTC Purchase Agreement with a value of $28.0 million. The unfunded exercise price of each pre-funded warrant is equal to $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantsMember_zxfr38GoJBii">0.00001 per underlying pre-funded warrant share. The exercise price and the number of shares of common stock issuable upon exercise of each pre-funded warrant is subject to appropriate adjustment in the event of certain stock dividends, stock splits, stock combinations, or similar events affecting the common stock. The pre-funded warrants are exercisable in cash or by means of a cashless exercise and will not expire until the date the pre-funded warrants are fully exercised. The pre-funded warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof (together with its affiliates) immediately following such exercise would exceed a specified beneficial ownership limitation; provided, however, that a holder may increase or decrease the beneficial ownership limitation by giving notice to the Company (61 days notice for increases), but not to any percentage in excess of 9.99%. As of March 31, 2026, <span id="xdx_90B_ecustom--WarrantsExercisedShares_c20250718__20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantsMember_zpJantSgOYRl" title="Exercised shares">5,457,013 of the pre-funded warrants issued in the Private Placements were exercised. There were <span id="xdx_90A_ecustom--WarrantsExercisedShares_do_c20260101__20260331__us-gaap--SubsidiarySaleOfStockAxis__custom--July2025PrivatePlacementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PreFundedWarrantsMember_zJc9NmeJ26b8">no exercises of these pre-funded warrants in the period from April 1, 2026 through May 7, 2026. Concurrent with the Purchase Agreements, the Company and the Purchasers entered into a Registration Rights Agreement, dated July 17, 2025 (the “Registration Rights Agreement”), providing for the registration for resale of the common shares and the pre-funded warrant shares sold in the Private Placements and the shares underlying the Gemini Warrants, the Placement Agent Warrants and the consultant warrant issued concurrent with the Private Placements that are not then registered on an effective registration statement, pursuant to a registration statement (the “Registration Statement”) to be filed with the SEC no later than August 16, 2025. The Company filed the Registration Statement on August 15, 2025 and it became effective on August 18, 2025 and has remained effective through the date of issuance of the financial statements as of and for the three months ended March 31, 2026. The Company has agreed to use reasonable best efforts to cause the Registration Statement to be declared effective no later than 60 days after closing of the Private Placements, and to keep the Registration Statement continuously effective from the date on which the SEC declares the Registration Statement to be effective until (i) the date on which the Purchasers shall have resold all the Registrable Securities (as such term is defined in the Registration Rights Agreement) covered thereby, or (ii) the date on which the Registrable Securities may be resold by the Purchasers without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144 as promulgated by the SEC under the Securities Act of 1933, as amended (the “Securities Act”), without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 or any other rule of similar effect. The Company granted the Purchasers customary indemnification rights in connection with the Registration Rights Agreement. The Purchasers also granted the Company customary indemnification rights in connection with the Registration Rights Agreement. February 2025 Offering On February 6, 2025, the Company consummated an underwritten public offering pursuant to which it received net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20250205__20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember_zw4q7vz5YYr2">10,703,882 from the sale of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20250205__20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember_zFJz1cqpUye7">53,750 common stock units, which consisted of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20250205__20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zv0hDIbVK8ui">53,750 shares of common stock and <span id="xdx_903_ecustom--WarrantsIssued_pp0p0_c20250205__20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zkv2t0wwAvO6">53,750 fully exercisable five-year warrants to purchase the Company’s common stock at $16.00 per share, and <span id="xdx_905_ecustom--PrefundedWarrantsIssued_pp0p0_c20250205__20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_zsyngzZmWBLb">696,250 pre-funded warrant units, which consisted of 696,250 pre-funded fully exercisable warrants with an exercise price of $0.00008 and 696,250 fully exercisable five-year warrants to purchase the Company’s common stock at $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pp0p0_c20250206__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--StatementClassOfStockAxis__custom--Warrants2Member_zkaV3BYTATke">16.00 per share (the “February 2025 Warrants”). As of March 31, 2026, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pp0p0_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--CommonStockUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--February2025StockSaleMember__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_zMHcCC7T8sci">355,626 pre-funded warrants have been exercised and no pre-funded warrants were exercised from April 1, 2026 to May 7, 2026. As of March 31, 2026, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pp0p0_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--PreFundedWarrantsMember_zXAyx6Xmk7m" title="Exercised warrants">111,500 February 2025 Warrants were exercised, and no February 2025 Warrants were exercised from April 1, 2026 to May 7, 2026. At the Market Program In 2024, the Company established an At the Market Program (“ATM”) with Aegis Capital Corp. (“Aegis”) as placement agent, pursuant to which it can sell up to $100.0 million of its common stock and is subject to a fee payable to Aegis Capital Corp. (“Aegis”) of <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_c20240101__20241231__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMMember__dei--LegalEntityAxis__custom--AegisCapitalCorpMember_zkjkqvYHVHac" title="Sale percentage">3%. During the three months ended March 31, 2025, the Company has received aggregate net proceeds of $8,846,761 for the sale of 220,515 shares of common stock through the ATM. On July 17, 2025, the Company entered into Amendment No.1 to the At-The-Market Issuance Sales Agreement (the “ATM Amendment Sales Agreement”) with Aegis which, among other matters, (i) increases the maximum capacity of the program by $1.0 billion and (ii) adjusts the fee Aegis will be paid as sales agent to <span id="xdx_907_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_c20250716__20250717__us-gaap--SubsidiarySaleOfStockAxis__custom--ATMMember__dei--LegalEntityAxis__custom--AegisCapitalCorpMember_zZViAO8ORPW4" title="Sale percentage">1% of gross proceeds of sales under the At-The-Market Issuance Sales Agreement for such additional amount. The Company filed a shelf registration statement to register the shares underlying such agreement on July 30, 2025, which was amended on March 26, 2026 and March 30, 2026. No shares have been sold under the ATM during 2026. Common Stock Repurchase Programs On March 21, 2025, the Company’s Board approved a common stock repurchase program whereby the Company could repurchase up to $2.0 million of common stock subject to a limitation that at least 500,000 shares of common stock must be outstanding to meet Nasdaq compliance rules. As of March 31, 2026, the Company has repurchased 65,348 shares of common stock at an average purchase price of $7.82 per share with cash of $510,907, including commissions paid of $<span id="xdx_908_eus-gaap--PaymentsForRepurchaseOfEquity_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--CommissionsPaidMember__us-gaap--AwardTypeAxis__custom--March2025StockBuybackProgramMember_zPqofM9Xkmnb" title="Repurchase of common stock">17,045, under the March 2025 stock repurchase program. On July 24, 2025, the Board approved a $100.0 million common stock repurchase program (increased by the Board to $150.0 million on October 10, 2025 and increased to $200.0 million on February 2, 2026) which terminated the March 2025 repurchase program. The authorization is effective through July 24, 2027, subject to extension or earlier termination by the Board at any time. The shares of common stock may be repurchased from time to time in open market transactions at prevailing market prices not to exceed $20.00 per share, in privately negotiated transactions, or by other means in accordance with federal securities laws. The actual timing, number and value of shares repurchased under the program will be determined by management at its discretion and will depend on a number of factors, including the market price of the common stock, general market and economic conditions and applicable legal requirements. The repurchase program does not obligate the Company to purchase any particular number of shares of common stock. As of March 31, 2026, the Company has repurchased 24,135,409 shares of common stock under the new repurchase program at an average purchase price of $5.80 per share with cash of $139,990,849, including commissions paid of $<span id="xdx_90F_eus-gaap--PaymentsForRepurchaseOfEquity_c20260101__20260331__us-gaap--TransactionTypeAxis__custom--CommissionsPaidMember__us-gaap--AwardTypeAxis__custom--NewRepurchaseProgramMember_zDma84Si8Zz2">1,366,680. For the period from April 1, 2026 to May 7, 2026, the Company has repurchased 2,109,248 shares of common stock at an average purchase price of $4.62 per share with cash of $9,750,633, including commissions paid of $96,541. These repurchases were funded from amounts borrowed under the borrowing agreements discussed in Note 5 above and from proceeds from the sale of Bitcoin discussed in Note 4. The shares repurchased under both repurchase programs and cash paid are presented as treasury stock in the condensed consolidated balance sheet as of March 31, 2026. Stockholder Rights Plan On February 3, 2026, the Board of Directors of the Company declared a dividend of one preferred share purchase right (a “Right”), payable on February 13, 2026, for each share of common stock, par value $0.00001 per share, of the Company outstanding on February 13, 2026 (the “Record Date”) to the stockholders of record on that date. In connection with the distribution of the Rights, the Company entered into a Rights Agreement (the “Rights Agreement”), dated as of February 3, 2026, between the Company and Computershare Trust Company, N.A., as rights agent. Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Preferred Stock, par value $0.00001 per share (the “Preferred Shares”), of the Company at a price of $15.00 per one one-thousandth of a Preferred Share represented by a Right, subject to adjustment. Unless the Rights are earlier redeemed or exchanged by the Company, the Rights Plan will expire at the close of business on February 2, 2027. The Rights are not exercisable until the Distribution Date, which is the earlier of (i) the Close of Business on the 10th day following a public announcement, or the public disclosure of facts indicating, that a Person or group of affiliated or associated Persons has become an “Acquiring Person” (or, in the event the Board of Directors determines to effect an exchange in accordance with Section 24 of the Rights Agreement and the Board of Directors determines that a later date is advisable, then such later date) or (ii) the Close of Business on the 10th Business Day (or such later date as may be determined by action of the Board of Directors prior to such time as any Person becomes an “Acquiring Person”) following the commencement of a tender offer or exchange offer the consummation of which would result in a Person or group becoming an “Acquiring Person.” An “Acquiring Person” means any person who becomes the beneficial owner of 12.5% or more of the outstanding shares of common stock of the Company, subject to certain specified exceptions set forth in the Rights Plan. Initially, the Rights are attached to all common stock certificates and no separate certificates evidencing the Rights (“Right Certificates”) were issued. As soon as practicable after the Distribution Date, unless the Rights are recorded in book-entry or other uncertificated form, the Company will prepare and cause the Right Certificates to be sent to each record holder of common stock as of the Distribution Date. If the Rights become exercisable, all holders of Rights (other than the Acquiring Person and its affiliates and associates, whose Rights would become void) will be entitled to acquire common stock having a value equal to two times the exercise price of the Right. In the event of a merger, consolidation, or sale of 50% or more of the Company’s assets following a person becoming an Acquiring Person, each Right would instead entitle the holder to purchase common stock of the acquiring company at the same two-times-value ratio. Alternatively, the Board may exchange each Right held by non-Acquiring Person holders for one share of common stock per Right. The Rights Plan also includes a “qualifying offer” provision under which the Rights will automatically expire if an all-shares, same-consideration tender or exchange offer is accepted for more than two-thirds of the outstanding common stock on a fully diluted basis, subject to a minimum 90 business-day period following commencement of the offer. The Board may redeem all of the Rights at a price of $0.00001 per Right at any time before a person becomes an Acquiring Person and may amend the terms of the Rights without holder consent, except that no amendment after a person becomes an Acquiring Person may adversely affect the interests of Rights holders. Series A Convertible Preferred Stock In connection with the Stockholder Rights Agreement implemented on February 3, 2026, the Company designated 100,000 shares of Preferred Stock as Series A with a par value of $0.00001 per share. Warrants Series A Warrants Each Series A Warrant had an initial exercise price per share equal to $158,400, was immediately exercisable upon issuance, and expires on the five-year anniversary of the original issuance date, or November 17, 2028. As of March 31, 2026, there are 10,008 Series A Warrants outstanding with an exercise price of $3.56. Cashless Exercise If at the time a holder exercises its Series A Warrants, a registration statement registering the issuance of the shares of common stock underlying the Series A Warrants under the Securities Act is not then effective or available and an exemption from registration under the Securities Act is not available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Series A Warrants. Conditioned upon the receipt of the Warrant Stockholder Approval at a required Special Meeting, a holder of Series A Warrants may also provide notice and elect an “alternative cashless exercise” pursuant to which they would receive an aggregate number of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash exercise of the Series A Warrant and (y) 3.0. Approval of this adjustment by the stockholders was made on January 12, 2024. Share Combination Event Adjustments If a share split, share dividend, share combination, recapitalization or other similar transaction involving the Company’s common stock (collectively a “Share Event”) and the lowest daily VWAP during the five consecutive trading days prior to the date of such event and the five consecutive trading days after the date of such event is less than the exercise price then in effect, then the exercise price of the Series A Warrant shall be reduced to the lowest daily VWAP during such period and the number of warrant shares issuable shall be increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, shall be equal to the aggregate exercise price on the date of issuance. Approval of this adjustment by the stockholders was made on January 12, 2024. Since issuance, the number of Series A Warrants have been adjusted under the Share Event provisions. See Note 7 for further discussion of the fair value of these warrants. Other Warrants As discussed in Note 8 above, the Company issued warrants to purchase up to 901,542 shares of common stock to Gemini or its designees (the “Gemini Warrants”) with an exercise price of $10.00 per share and a 10-year term. The Gemini Warrants began vesting and became exercisable on July 21, 2025 in accordance with the Applicable Vesting Schedule. Based on the highest VWAP of the Company’s common stock from July 21, 2025, 360,618 warrants have vested as of March 31, 2026. The Company issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--PlacementAgentWarrantsMember_zdatNY5GiGa1" title="Warrants issued">163,929 warrants to purchase shares of common stock to the placement agents of the Private Placements (the “Placement Agent Warrants”) with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--PlacementAgentWarrantsMember_z4gpseWLAz38" title="Exercise price">10.00 per share and a five-year term. The Placement Agents Warrants began vesting and became exercisable on July 21, 2025 based on the Applicable Vesting Schedule. Based on the highest VWAP of the Company’s common stock since July 21, 2025, 65,573 warrants have vested as of March 31, 2026. The Company has determined that the Gemini Warrants and the Placement Agent Warrants should be classified as equity. Since the first 20% of these warrants vest if the Company’s daily VWAP is $<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20260101__20260331__us-gaap--SubsidiarySaleOfStockAxis__custom--GeminiWarrantsMember_zfjLXS2w1zC3" title="Warrants vest">10.00 and the Private Placements priced at $<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementsMember_z2kj40wxxKt" title="Warrants vest">10.00, the Company concluded that the first tranche was certain to vest at the time of grant, which was the same day the Purchase Agreements were executed by investors for the Private Placements and used a Black-Scholes option pricing model. Since the daily VWAP beyond $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20260101__20260331__us-gaap--DerivativeInstrumentRiskAxis__custom--MonteCarloSimulationMember_zilYecxhGTG5" title="Warrants vest">10.00 was uncertain, the Company used Monte Carlo simulation to estimate the value of the remaining tranches of these warrants. The following assumptions were used in the Black Scholes option pricing models and Monte Carlo simulations: <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zS6Ds1fHfn25" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Company stock price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20260331_zLFBOxNggFQk" style="width: 13%; text-align: right" title="Company stock price on valuation date">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143.85%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk free interest rate - 5 years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_c20260101__20260331_zsmtF78LANNc" title="Risk free interest rate - 5 years">3.94%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate - 10 years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20260101__20260331_zVKZ7pzqy2J9" title="Risk free interest rate - 10 years">4.43%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td></tr> </table> Based on the above inputs, the following fair values and derived service periods were calculated: <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zOvfOSkR3QQf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Fair values and derived services)"> <tr style="vertical-align: bottom"> <td>Schedule of fair values and derived service periods</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $10</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $15</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $20</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $25</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 35%">Fair value - 5 year service period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP10Member_ztP34p29MOwc" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP15Member_zS2sVNfWuqY" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP20Member_zxZUJd1GK0xk" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP25Member_zY6kIVjEvVE8" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP30Member_zE2OohUNGR44" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derived service period - years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.69</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Fair value - 10 year service period</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP10Member_zpeSUq9ZF2k3" style="text-align: right" title="Fair value - 10 year service period">9.82</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP15Member_zPN6gZ7PAedc" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP20Member_zu73ibM4BTr9" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP25Member_zuMphzbnQ8H8" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP30Member_zHmMpib8pUme" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derived service period - years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.73</td><td style="text-align: left"> </td></tr> </table> The Company’s highest VWAP in the period from July 21, 2025 to March 31, 2026 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_c20250720__20251231_zZukGEVv3mqf" title="Share price">18.77. Therefore the first two tranches vested and the Company recognized all of the expense for these tranches as of March 31, 2026. The Company recognized expense on the remaining unvested tranches based on the derived service periods and number of days vesting in the period ended March 31, 2026. The Company recognized total expense of $1,478,640 for the Placement Agent Warrants and recorded this as offering costs related to the Private Placements. The Company recognized total expense of $<span id="xdx_905_eus-gaap--OtherGeneralAndAdministrativeExpense_c20260101__20260331__us-gaap--SubsidiarySaleOfStockAxis__custom--GeminiWarrantsMember_zC6csjHDvdHa" title="General and administrative expense">1,026,587 in general and administrative expense for the Gemini warrants for the three months ended March 31, 2026. Remaining expense to be recognized for the Placement Agent Warrants and Gemini Warrants are $0 and $92,789, respectively, which will be recognized over the remaining derived service periods for each tranche unless the daily VWAP exceeds the vesting price for the tranche, in which case the expense will be recognized immediately. In addition, concurrent with the closing of the Private Placements, the Company issued fully vested warrants to a consultant to purchase up to <span id="xdx_909_ecustom--WarrantsPurchase_c20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CounterpartyNameAxis__custom--ConsultantMember_znr5CRtif2j5" title="Warrants purchase">25,000 shares of common stock with an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CounterpartyNameAxis__custom--ConsultantMember_zmPhjl1qyyA3" title="Exercise price">10.00 per share of common stock and a <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20260101__20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CounterpartyNameAxis__custom--ConsultantMember_ze1mMH8Uo7I8" title="Term::XDX::P10Y">ten-year term. The Company valued these warrants using a Black-Scholes option pricing model using the same ten-year inputs noted above. The Company recognized expense of $<span id="xdx_904_eus-gaap--OtherGeneralAndAdministrativeExpense_c20250701__20250930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ze7Sf1KdK8T" title="General and administrative expense">249,413 in general and administrative expense for the three months ended September 30, 2025. The following is the activity related to pre-funded common stock warrants during the three months ended March 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPrefundedCommonStockWarrantsActivityTableTextBlock_zV85laQIHFhf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Pre-funded warrants activity)"> <tr style="vertical-align: bottom"> <td>Schedule of pre-funded common stock warrants</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Pre- Funded Common Stock Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years(1)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zX5aDAl69T57" style="width: 11%; text-align: right" title="Number of shares outstanding, Beginning">3,913,538</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zlS1MTUzYXR1" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, Beginning">0.00002</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchased</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zVDI1l5tMkr2" style="text-align: right" title="Shares, Purchased">2,079,797</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zzmHIcZkpzFh" style="text-align: right" title="Weighted average exercise price, Purchased">0.00001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zr4dh8lVbPNb" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercised">(3,396,940</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExercisedWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zhfdPFxh2ykb" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Exercised">0.00001</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zHTdkW9vHNjd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, Ending">2,596,395</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zx5KjWGGEShf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending">0.00002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_z0ErojxYiMkj" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Outstanding">10,982,701</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zI9mMbj2WmMc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercisable">2,596,395</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_z0aihnLwVPx" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable">0.00002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zjZuraPUyGpf" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Exercisable">10,982,701</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%">(1)</td> <td style="width: 94%; text-align: justify">Pre-funded warrants expire only upon exercise</td></tr> </table> The following is the activity related to all common stock warrants, excluding pre-funded warrants, during the three months ended March 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zEcBkz9b3GI1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Stock warrants activity)"> <tr style="vertical-align: bottom"> <td>Schedule of warrants activity</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other Common Stock Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zNuG3xwezp8" style="width: 11%; text-align: right" title="Number of shares outstanding, Beginning">1,735,349</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zp9wflyfPxP9" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, Beginning">47.66</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted/purchased</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_fKDEp_zIxMdHzsq5kf" style="text-align: right" title="Shares, Granted/purchased">4,643,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_fKDEp_zkV6VKfk1SB2" style="text-align: right" title="Weighted average exercise price, Granted/purchased">6.26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zzIXgdUlwrO4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercised">(2</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExercisedWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zrD7VXw1gGel" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Exercised">2,571,840</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zw3JQoiF2YPj" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, Ending">6,378,834</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zvnCn26XfEIa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending">16.72</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zIzButruXPrg" title="Weighted average remaining life in years, Outstanding">4.73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zXD4W1FxYC47" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Outstanding">6,705</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iI_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zkTGes716Du7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercisable">5,739,551</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_z8IitGjaK1j7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable">18.58</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zunV58lIMO24" title="Weighted average remaining life in years, Exercisable">4.73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_z0tLPmBzDmb2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Exercisable">6,705</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

250000000

5000000

0.00001

941

24787679

2558422

2558422 2079797

2079797

100000

892709

44414189

5728662

501000000

21000000

0.00001

5457013 0

10703882

53750

53750 696250

16.00

355626

111500

100000000

0.03

8846761

220515

1000000000

0.01

2000000

65348

510907

17045

100000000 150000000 200000000

20.00

24135409

139990849

1366680

0.00001

15.00

100000

158400

2028-11-17

10008

3.56

901542

10.00

P10Y

360618

163929

10.00

65573

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zS6Ds1fHfn25" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Company stock price on valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20260331_zLFBOxNggFQk" style="width: 13%; text-align: right" title="Company stock price on valuation date">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143.85%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk free interest rate - 5 years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_c20260101__20260331_zsmtF78LANNc" title="Risk free interest rate - 5 years">3.94%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate - 10 years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20260101__20260331_zVKZ7pzqy2J9" title="Risk free interest rate - 10 years">4.43%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td></tr> </table>

10.00

1.4385

0.0394

0.0443

0.0000

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zOvfOSkR3QQf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Fair values and derived services)"> <tr style="vertical-align: bottom"> <td>Schedule of fair values and derived service periods</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $10</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $15</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $20</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $25</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Daily VWAP $30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 35%">Fair value - 5 year service period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP10Member_ztP34p29MOwc" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP15Member_zS2sVNfWuqY" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP20Member_zxZUJd1GK0xk" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP25Member_zY6kIVjEvVE8" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePriceFairValueFiveYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP30Member_zE2OohUNGR44" style="width: 9%; text-align: right" title="Fair value - 5 year service period">9.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derived service period - years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.69</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Fair value - 10 year service period</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP10Member_zpeSUq9ZF2k3" style="text-align: right" title="Fair value - 10 year service period">9.82</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP15Member_zPN6gZ7PAedc" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP20Member_zu73ibM4BTr9" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP25Member_zuMphzbnQ8H8" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAverageExercisePriceFairValueTenYearsServicePeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--DailyVWAP30Member_zHmMpib8pUme" style="text-align: right" title="Fair value - 10 year service period">9.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derived service period - years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.73</td><td style="text-align: left"> </td></tr> </table>

9.03 9.02 9.02 9.02 9.01 0.20 0.38 0.56 0.69 9.82 9.80 9.80 9.80 9.80 0.20 0.40 0.58 0.73

18.77

1478640

1026587

92789

25000

10.00

249413

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfPrefundedCommonStockWarrantsActivityTableTextBlock_zV85laQIHFhf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Pre-funded warrants activity)"> <tr style="vertical-align: bottom"> <td>Schedule of pre-funded common stock warrants</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Pre- Funded Common Stock Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years(1)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zX5aDAl69T57" style="width: 11%; text-align: right" title="Number of shares outstanding, Beginning">3,913,538</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zlS1MTUzYXR1" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, Beginning">0.00002</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchased</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zVDI1l5tMkr2" style="text-align: right" title="Shares, Purchased">2,079,797</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zzmHIcZkpzFh" style="text-align: right" title="Weighted average exercise price, Purchased">0.00001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zr4dh8lVbPNb" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercised">(3,396,940</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExercisedWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zhfdPFxh2ykb" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Exercised">0.00001</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zHTdkW9vHNjd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, Ending">2,596,395</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zx5KjWGGEShf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending">0.00002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_z0ErojxYiMkj" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Outstanding">10,982,701</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zI9mMbj2WmMc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercisable">2,596,395</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_z0aihnLwVPx" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable">0.00002</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_c20260331__us-gaap--AwardTypeAxis__custom--PreFundedCommonStockWarrantsMember_zjZuraPUyGpf" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Exercisable">10,982,701</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%">(1)</td> <td style="width: 94%; text-align: justify">Pre-funded warrants expire only upon exercise</td></tr> </table>

3913538

0.00002

2079797

0.00001

3396940

0.00001

2596395

0.00002

10982701

2596395 0.00002 10982701

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zEcBkz9b3GI1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Stock warrants activity)"> <tr style="vertical-align: bottom"> <td>Schedule of warrants activity</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Other Common Stock Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zNuG3xwezp8" style="width: 11%; text-align: right" title="Number of shares outstanding, Beginning">1,735,349</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zp9wflyfPxP9" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, Beginning">47.66</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted/purchased</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_fKDEp_zIxMdHzsq5kf" style="text-align: right" title="Shares, Granted/purchased">4,643,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_fKDEp_zkV6VKfk1SB2" style="text-align: right" title="Weighted average exercise price, Granted/purchased">6.26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zzIXgdUlwrO4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercised">(2</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionExercisedWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zrD7VXw1gGel" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, Exercised">2,571,840</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zw3JQoiF2YPj" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, Ending">6,378,834</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zvnCn26XfEIa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstanding, Ending">16.72</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zIzButruXPrg" title="Weighted average remaining life in years, Outstanding">4.73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zXD4W1FxYC47" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Outstanding">6,705</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iI_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zkTGes716Du7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, Exercisable">5,739,551</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_z8IitGjaK1j7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Exercisable">18.58</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_zunV58lIMO24" title="Weighted average remaining life in years, Exercisable">4.73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__custom--CommonStockWarrantsMember_z0tLPmBzDmb2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, Exercisable">6,705</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

1735349

47.66

4643487

6.26

2571840

6378834

16.72

P4Y8M23D

6705

5739551 18.58

P4Y8M23D

6705

NOTE 10 – STOCK-BASED COMPENSATION 2025 Stock Plan As discussed in Note 9, in conjunction with the digital asset treasury strategy and Private Placements, on July 16, 2025, the Company’s Board adopted the 2025 Stock Plan (the “2025 Plan”) and granted stock options to certain employees, Board members and a consultant. A total of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250715__20250717__us-gaap--PlanNameAxis__custom--StockPlan2025Member_zgRVHfkP9BId" title="Number of shares granted">5,681,381 stock options were granted to purchase the Company’s common stock at $10.00 per share with a <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20250715__20250717__us-gaap--PlanNameAxis__custom--StockPlan2025Member_zSvKavwa4Vsb" title="Term::XDX::P10Y">ten-year term, regardless of service being provided and only forfeitable in the event employment is terminated for cause as defined in the stock option agreement. These stock options vest based on the Applicable Vesting Schedule. The Company’s highest VWAP in the period from July 17, 2025 to March 31, 2026 was $<span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20250718__20260331__us-gaap--PlanNameAxis__custom--StockPlan2025Member_z01mBt2XHnzb" title="Vested share price">29.86, and accordingly the first four tranches vested. Since these stock options are not exercisable until the 2025 Stock Plan and shares to be issued under the 2025 Stock Plan are approved by the Company’s stockholders, the Company has not recorded any share-based compensation expense for these stock options as there is no measurement date since stockholder approval is uncertain. If stockholder approval is obtained, the Company will value these options and recognize share-based compensation for any vested awards and any unvested awards based on the derived service period. Inducement Stock Options Also in connection with the Private Placements, the Board approved <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember__srt--CounterpartyNameAxis__custom--TwoExecutivesAndOneEmployeeMember_zfBNw9JAkIX9" title="Number of shares granted">1,045,807 inducement stock option grants to purchase the Company’s common stock with an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember__srt--CounterpartyNameAxis__custom--TwoExecutivesAndOneEmployeeMember_zLu2cjF4Mckj" title="Exercise price">10.00 to two executives (see Note 8 above) and one employee. These stock options have a <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20260101__20260331__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_zpecuDlmKUEd" title="Term::XDX::P10Y">ten-year term regardless of continued employment with the Company, provided that the employee is not terminated for cause. These stock options vest based on the Applicable Vesting Schedule. The Company used a Black Scholes option pricing model and Monte Carlo simulation to value these stock options consistent with the Placement Agent Warrants (see Note 9) since the Company determined the expected life of these options is approximately <span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_zzAmg1qiW98b" title="Expected life">5 years. Based on the highest VWAP of the Company’s common stock since the Private Placements, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20260331__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_z2pxGGh6Hxz1" title="Number of shares vested">836,648 stock options have vested as of March 31, 2026. For the three months ended March 31, 2026, the Company recognized expense of $677,665 in general and administrative expense for these inducement stock options and there is no remaining expense to be recognized. In August 2024, as part of the compensation package for the Company’s Chief Sales Officer (“CSO”), the Company granted <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240801__20240831__srt--TitleOfIndividualAxis__custom--ChiefSalesOfficerMember__us-gaap--PlanNameAxis__custom--Plan2021Member__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_zryUFGAcPjG" title="Number of shares granted">782 stock options outside of the 2021 Plan with an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240801__20240831__srt--TitleOfIndividualAxis__custom--ChiefSalesOfficerMember__us-gaap--PlanNameAxis__custom--Plan2021Member__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_zfdAachfhB08" title="Exercise price">104.32. In June 2025, the Company cancelled these stock options and paid $<span id="xdx_90F_eus-gaap--StockOptionPlanExpense_c20250601__20250630__srt--TitleOfIndividualAxis__custom--ChiefSalesOfficerMember__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_ziiWUOBFDYKi" title="Payment for stock option">4,252 to the CSO. The Company recognized a net benefit of $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20260101__20260331__srt--TitleOfIndividualAxis__custom--ChiefSalesOfficerMember__us-gaap--AwardTypeAxis__custom--InducementStockOptionsMember_zDJvfV45i7P3" title="Share-based compensation">30,932 for the share-based compensation expense previously recognized on the unvested stock options less the cash paid. 2021 Stock Plan In January 2021, the Company’s Board of Directors adopted the Volcon, Inc. 2021 Stock Plan, (the “2021 Plan”). The 2021 Plan is a stock-based compensation plan that provides for discretionary grants of stock options, stock awards, and restricted stock unit (“RSU”) awards to employees, members of the Board of Directors and consultants (including restricted stock units issued prior to the adoption of the plan as further discussed below). The Company has reserved 39 shares of the Company’s common stock for issuance under the 2021 Plan. To the extent that an award, if forfeitable, expires, terminates or lapses, or an award is otherwise settled in cash without the delivery of shares of common stock to the participant, then any unpaid shares subject to the award will be available for future grant or issuance under the 2021 Plan. There are <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_do_c20260331__us-gaap--PlanNameAxis__custom--Volcon2021PlanMember_zid2wCts9J93" title="Number of shares granted">no shares available for issuance under the 2021 Plan as of March 31, 2026. Awards vest according to each agreement and as long as the employee remains employed with the Company or the consultant continues to provide services in accordance with the terms of the agreement. Other As discussed in Note 8 above, fully vested stock options were granted to one of the Company’s Co-CEOs and CFO to purchase a total of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20260101__20260331__srt--TitleOfIndividualAxis__custom--CEOAndCFOMember_zSd5wEweKW7g" title="Number of shares grant">252,525 shares of the Company’s common stock at $4.56 per share. The Company recognized share-based compensation of $1,125,802 related to these stock options in the year ended December 31, 2025. On July 17, 2025, the Co-CEO and CFO amended these stock options to reset the exercise price to $10.00 per share. There was no impact to share-based compensation for this modification as the fair value immediately after the modification was less than the fair value immediately before the modification. The following summarizes activity relating to common stock options to employees and consultants for services during the three months ended March 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z9dP1HyjsOxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details - Stock option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of stock options activity</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSwwSZ0rnw58" style="width: 11%; text-align: right" title="Shares outstanding, beginning balance">1,298,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z90Q5qCPSeNd" style="width: 11%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">76.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWBVWHcOvEhf" style="width: 11%; text-align: right" title="Intrinsic value, outstanding at beginning">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zg0wt3jU6H5a" style="text-align: right" title="Shares outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTiuqHI2yti3" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z31R1RZPzCzk" style="text-align: right" title="Shares outstanding, forfeited">(30</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zKyVjJyVbi5a" style="text-align: right" title="Weighted average exercise price, forfeited">2,077,665.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Canceled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0pZEOSDE1p6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, canceled">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zguaQuc8V9nj" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, canceled">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztoQtXkjyYwa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, ending balance">1,298,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAF1d012j4ka" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, outstanding ending balance">21.85</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHHcIOEE0Nui" title="Weighted average remaining life in years, outstanding">9.25</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zUgy4hbnVil6" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, outstanding at ending">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhw50Y6dJmPj" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, exercisable">1,089,177</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD7L2tAVQRIc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercisable">24.12</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjcNkWYYmaS1" title="Weighted average remaining life in years, exercisable">9.25</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrW7I6LJMbG5" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, exercisable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> Total stock-based compensation recorded for the three months ended March 31, 2026 and 2025 for all stock-based compensation awards, including warrants, has been recorded as follows: <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zCbkk0L9I6nd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details - Compensation awards)"> <tr style="vertical-align: bottom"> <td>Schedule of stock-based compensation expense</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cost of Goods Sold</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--CostOfGoodsSoldMember_zVGNxNfG9xjb" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--CostOfGoodsSoldMember_zlFILdmFTHd2" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left">Sales and Marketing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--SalesAndMarketingMember_z86DaQebVbj6" style="width: 13%; text-align: right" title="Stock-based compensation">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--SalesAndMarketingMember_zTbMysMk0GR" style="width: 13%; text-align: right" title="Stock-based compensation">10,052</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Product Development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--ProductDevelopmentMember_zsm5SLv7OM76" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--ProductDevelopmentMember_zGRmWHhzjZga" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">General and Administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--GeneralAndAdministrativeMember_zSxhZfEUKb2f" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation">1,704,252</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--GeneralAndAdministrativeMember_zanyw27YlRzc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pp0p0_c20260101__20260331_zB6N2Acb4Bng" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,704,252</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20250101__20250331_zv9BKUqrNACa" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock-based compensation">10,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

5681381

10.00

29.86

1045807

10.00

P5Y

836648

677665

782

104.32

4252

30932

252525

4.56

1125802

10.00

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z9dP1HyjsOxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details - Stock option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of stock options activity</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Life in years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at January 1, 2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSwwSZ0rnw58" style="width: 11%; text-align: right" title="Shares outstanding, beginning balance">1,298,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z90Q5qCPSeNd" style="width: 11%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">76.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWBVWHcOvEhf" style="width: 11%; text-align: right" title="Intrinsic value, outstanding at beginning">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zg0wt3jU6H5a" style="text-align: right" title="Shares outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTiuqHI2yti3" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z31R1RZPzCzk" style="text-align: right" title="Shares outstanding, forfeited">(30</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zKyVjJyVbi5a" style="text-align: right" title="Weighted average exercise price, forfeited">2,077,665.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Canceled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0pZEOSDE1p6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, canceled">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zguaQuc8V9nj" style="padding-bottom: 1pt; text-align: right" title="Weighted average exercise price, canceled">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztoQtXkjyYwa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, ending balance">1,298,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAF1d012j4ka" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, outstanding ending balance">21.85</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHHcIOEE0Nui" title="Weighted average remaining life in years, outstanding">9.25</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_d0_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zUgy4hbnVil6" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, outstanding at ending">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhw50Y6dJmPj" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding, exercisable">1,089,177</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD7L2tAVQRIc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercisable">24.12</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjcNkWYYmaS1" title="Weighted average remaining life in years, exercisable">9.25</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_d0_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrW7I6LJMbG5" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic value, exercisable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

1298366

76.25

2077665.88

1298336

21.85

P9Y3M

1089177

24.12

P9Y3M

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zCbkk0L9I6nd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details - Compensation awards)"> <tr style="vertical-align: bottom"> <td>Schedule of stock-based compensation expense</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cost of Goods Sold</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--CostOfGoodsSoldMember_zVGNxNfG9xjb" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--CostOfGoodsSoldMember_zlFILdmFTHd2" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left">Sales and Marketing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--SalesAndMarketingMember_z86DaQebVbj6" style="width: 13%; text-align: right" title="Stock-based compensation">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--SalesAndMarketingMember_zTbMysMk0GR" style="width: 13%; text-align: right" title="Stock-based compensation">10,052</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Product Development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--ProductDevelopmentMember_zsm5SLv7OM76" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--ProductDevelopmentMember_zGRmWHhzjZga" style="text-align: right" title="Stock-based compensation">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">General and Administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20260101__20260331__us-gaap--NatureOfExpenseAxis__custom--GeneralAndAdministrativeMember_zSxhZfEUKb2f" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation">1,704,252</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pp0p0_d0_c20250101__20250331__us-gaap--NatureOfExpenseAxis__custom--GeneralAndAdministrativeMember_zanyw27YlRzc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensation_pp0p0_c20260101__20260331_zB6N2Acb4Bng" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,704,252</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20250101__20250331_zv9BKUqrNACa" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock-based compensation">10,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

10052

1704252

10052

NOTE 11 – LOSS PER COMMON SHARE The basic net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the weighted average number of Common Stock during the three months ended March 31, 2026 and 2025. The diluted net loss per common share is calculated by dividing the Company’s net loss available to common stockholders by the diluted weighted average number of Common Stock outstanding during the year. The diluted weighted average number of Common Stock outstanding is the basic weighted number of Common Stock adjusted for any potentially dilutive debt or equity. Diluted net loss per common share is equal to basic net loss per share due to the Company’s net loss and any potentially issuable shares are anti-dilutive. <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zILCoSoY9KRl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Earnings Per Share)"> <tr style="vertical-align: bottom"> <td>Schedule of basic loss per common share</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20260101__20260331_ziP6rYb2Z7U9" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20250101__20250331_z5z89HPyohh5" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_ecustom--NumeratorAbstract_iB_zP3z6aqYK3Jc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperations_z5AfOHNZJo12" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Loss from continuing operations</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(85,403,548</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(2,076,375</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_d0_z8jTtfWI3MAk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss from discontinued operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(384,055</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zO6RgMCRENo4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(85,403,548</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,460,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DenominatorAbstract_iB_zZkt6GHLXEyf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Denominator for basic and diluted net loss per common share - weighted average of common shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">33,022,103</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">338,235</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from continuing operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.59</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6.13</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from discontinued operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.14</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted net loss per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.59</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(7.27</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table> As discussed in Note 2 above, the Company received notice from DTCC on behalf of the brokerage firms that hold the shares of Company common stock held in “street name” that in connection with the foregoing rounding of shares the Company would need to issue <span id="xdx_90F_ecustom--CommonStockToBeIssuedForDisputedSharesFromNovember2024ReverseStockSplit_c20241118__20241119__srt--CounterpartyNameAxis__custom--DTCCStreetNameMember_z8IysjmoSl8k" title="Number of shares to be issued">23,617 shares of common stock which are not included in the amounts above. If these shares had been issued as of November 19, 2024 when notice from DTCC was received, the amounts for basic and diluted net loss per common share for the three months ended March 31, 2025 would be as follows: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_z0wOBSdV2tW3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Earnings Per Share)"> <tr style="vertical-align: bottom"> <td>Schedule of loss per common share</td><td> </td> <td colspan="2" id="xdx_491_20260101__20260331_zuuwdu3mUZq3" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--DenominatorAbstract_iB_ze8XJzzsUF57" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Denominator for basic and diluted net loss per common share - weighted average of common shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zE5RmpfTnYM9" title="Denominator for basic net loss per common share - weighted average of common shares"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_z2UzQEZa15z5" title="Denominator for diluted net loss per common share - weighted average of common shares">361,861</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from continuing operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zpVXWfRJGSZj" title="Continuing operations per common share, Basic"><span id="xdx_901_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zF1i7XpRF4r" title="Continuing operations per common share, Diluted">(5.74</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from discontinued operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zVVI6GPUL3ne" title="Discontinued operations per common share,Basic"><span id="xdx_90E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zTJ1f251N0i2" title="Discontinued operations per common share, Diluted">(1.06</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted net loss per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zLcS3ZnMYtbl" title="Basic net loss per common share"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zGSG9T5rVd3j" title="Diluted net loss per common share">(6.80</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table> Common shares consisting of shares potentially dilutive as of March 31, 2026 and 2025 are as follows: <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zD6eImMpTWch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of common shares consisting of shares potentially dilutive</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zXetX8m8VEGl" style="width: 13%; text-align: right" title="Antidilutive shares">8,975,229</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zenbqQrVg0Q8" style="width: 13%; text-align: right" title="Antidilutive shares">1,297,998</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z71YruRCqCtf" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">1,298,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zA7wiwm86oa7" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">786</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_zj4i1JKuZZD5" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">10,273,565</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zTxRJevqxfFa" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">1,298,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zILCoSoY9KRl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Earnings Per Share)"> <tr style="vertical-align: bottom"> <td>Schedule of basic loss per common share</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20260101__20260331_ziP6rYb2Z7U9" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20250101__20250331_z5z89HPyohh5" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_ecustom--NumeratorAbstract_iB_zP3z6aqYK3Jc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperations_z5AfOHNZJo12" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Loss from continuing operations</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(85,403,548</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(2,076,375</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_d0_z8jTtfWI3MAk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss from discontinued operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(384,055</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zO6RgMCRENo4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(85,403,548</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,460,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DenominatorAbstract_iB_zZkt6GHLXEyf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Denominator for basic and diluted net loss per common share - weighted average of common shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">33,022,103</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">338,235</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from continuing operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.59</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6.13</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from discontinued operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.14</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted net loss per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.59</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(7.27</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table>

-85403548

-2076375

-384055

-85403548

-2460430

33022103

338235

-2.59

-6.13

-1.14

-2.59

-7.27

23617

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_z0wOBSdV2tW3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Earnings Per Share)"> <tr style="vertical-align: bottom"> <td>Schedule of loss per common share</td><td> </td> <td colspan="2" id="xdx_491_20260101__20260331_zuuwdu3mUZq3" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--DenominatorAbstract_iB_ze8XJzzsUF57" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Denominator for basic and diluted net loss per common share - weighted average of common shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zE5RmpfTnYM9" title="Denominator for basic net loss per common share - weighted average of common shares"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_z2UzQEZa15z5" title="Denominator for diluted net loss per common share - weighted average of common shares">361,861</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from continuing operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zpVXWfRJGSZj" title="Continuing operations per common share, Basic"><span id="xdx_901_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zF1i7XpRF4r" title="Continuing operations per common share, Diluted">(5.74</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted loss from discontinued operations per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zVVI6GPUL3ne" title="Discontinued operations per common share,Basic"><span id="xdx_90E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zTJ1f251N0i2" title="Discontinued operations per common share, Diluted">(1.06</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Basic and diluted net loss per common share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zLcS3ZnMYtbl" title="Basic net loss per common share"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--DTCCMember_zGSG9T5rVd3j" title="Diluted net loss per common share">(6.80</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> </table>

361861

-5.74

-1.06

-6.80

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zD6eImMpTWch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LOSS PER COMMON SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of common shares consisting of shares potentially dilutive</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zXetX8m8VEGl" style="width: 13%; text-align: right" title="Antidilutive shares">8,975,229</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zenbqQrVg0Q8" style="width: 13%; text-align: right" title="Antidilutive shares">1,297,998</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_z71YruRCqCtf" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">1,298,336</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zA7wiwm86oa7" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">786</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_zj4i1JKuZZD5" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">10,273,565</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zTxRJevqxfFa" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">1,298,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

8975229

1297998

1298336

786

10273565

1298784

NOTE 12 – INCOME TAXES Due to losses since inception and for all periods presented, no income tax benefit or expense has been recognized as a full valuation allowance has been established for any tax benefit that would have been recognized for the loss in any period presented. The Company has recorded no liability for income taxes associated with unrecognized tax benefits at the date of adoption and has not recorded any liability associated with unrecognized tax benefits. Accordingly, the Company has not recorded any interest or penalty in regard to any unrecognized benefit.

NOTE 13 – DISCONTINUED OPERATIONS As discussed in Note 1 above, on October 15, 2025, the Company entered into the Venom APA with Venom, to divest the Volcon brand in exchange for a non-dilutable 10% equity position in Venom’s reorganized Delaware corporation on a fully-diluted basis, which reorganization has not occurred as of May 7, 2026 and will be recognized by the Company once completed. The Company transferred all Volcon IP, including all intellectual property, brand assets, trademarks, sales and distribution networks and engineering documentation associated with the Volcon brand (the “IP”) other than its E-Bike, the Brat. The Company will have the right to appoint one director to Venom’s board and may continue to finance Venom’s inventory purchases. In the event that Venom does not complete its corporate reorganization within six months, the Company will have the option to repurchase the Volcon IP for a nominal amount. The Company concluded that it would shift its business operations in the fourth quarter after the implementation of the digital asset treasury strategy. The Company expects that by selling the four-wheel product business, which includes the HF1 UTV, MN1 Tradesman UTV and MN1 Adventurer UTV products (collectively the “Divested Products”), it will reduce the Company’s future product liability exposure. Although the Company may continue to finance Venom’s inventory purchases and obtain a seat on Venom’s board of directors, the Company has concluded that it does not have significant ongoing involvement in the products sold in the Venom APA. The revenue and expenses associated with the Divested Products are presented as discontinued operations. Expenses also include certain allocated costs such as salaries, benefits, travel, marketing and consulting costs which are allocated based on actual costs or estimated time that individuals worked on these products. Following this divestiture, the Company will concentrate on its two-wheel business, including the launch of new products in the U.S. and Europe. The Company also plans to expand its inventory financing operations to generate positive cash flow by leveraging the spread between the Company’s cost of capital and interest income. Revenues and expenses for the two-wheel business and inventory financing business will be presented in the loss from continuing operations. Although the Company transferred the tradenames, design patents and engineering drawings for the Grunt, Grunt EVO and Stag in the Venom APA, the Company had discontinued the sale of these products before the shift in operations therefore revenues and costs associated with these products are also presented in the loss from continuing operations. The following table presents the carrying amount of the major classes of assets and liabilities included in the consolidated balance sheet that are related to discontinued operations: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zpQngL6r6sEe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details - Assets and liabilities)"> <tr style="vertical-align: bottom"> <td>Schedule of assets and liabilities included discontinued operations</td><td> </td> <td colspan="2" id="xdx_495_20251231_zRe3PFUAXofc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_iB_ze1VAuLW5NA8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zwz151E2BDV4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">256,459</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iI_z3moNfw1xsO9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Inventory</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,654</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperation_iI_z731mBLRTWoi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">268,113</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_iB_zglNoYWoJXXk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">LIABILITIES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayable_iI_z6NRkP12VbF6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">76,290</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_iI_zCE8d1pnGHqg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,732</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_iI_zQPyhC3tdWXc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">93,022</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table presents the major classes of line items representing the loss on discontinued operations: <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfLossOnDiscontinuedOperationsTableTextBlock_zvy8aoyPJ6sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details - Loss on discontinued operations)"> <tr style="vertical-align: bottom"> <td>Schedule of loss on discontinued operations</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20250101__20250331_zetzLfo2xDIi" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zcA2aR7yLmX3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">273,717</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_iN_di_zqjetWQmGe0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cost of goods sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(276,791</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing_zayxWbiiKiMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(214,733</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationProductDevelopment_zBdLGY5tUglg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Product development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(153,871</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_iN_di_zXhSMOJfGshg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,377</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zQd0yWTUhF32" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Loss from discontinued operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(384,055</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> The impact to the balance sheet as of March 31, 2026 and statement of cash flows for discontinued operations was not material for any period presented.

0.10

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zpQngL6r6sEe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details - Assets and liabilities)"> <tr style="vertical-align: bottom"> <td>Schedule of assets and liabilities included discontinued operations</td><td> </td> <td colspan="2" id="xdx_495_20251231_zRe3PFUAXofc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_iB_ze1VAuLW5NA8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zwz151E2BDV4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">256,459</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iI_z3moNfw1xsO9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Inventory</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,654</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperation_iI_z731mBLRTWoi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">268,113</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_iB_zglNoYWoJXXk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">LIABILITIES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayable_iI_z6NRkP12VbF6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">76,290</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_iI_zCE8d1pnGHqg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,732</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_iI_zQPyhC3tdWXc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">93,022</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

256459

11654

268113

76290

16732

93022

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfLossOnDiscontinuedOperationsTableTextBlock_zvy8aoyPJ6sc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details - Loss on discontinued operations)"> <tr style="vertical-align: bottom"> <td>Schedule of loss on discontinued operations</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20250101__20250331_zetzLfo2xDIi" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zcA2aR7yLmX3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">273,717</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_iN_di_zqjetWQmGe0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cost of goods sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(276,791</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing_zayxWbiiKiMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(214,733</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationProductDevelopment_zBdLGY5tUglg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Product development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(153,871</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_iN_di_zXhSMOJfGshg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,377</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zQd0yWTUhF32" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Loss from discontinued operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(384,055</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

273717

276791

-214733 -153871

12377

-384055

NOTE 14 – SUBSEQUENT EVENTS On February 26, 2026, a stockholder submitted a nomination notice purportedly naming nine candidates for election to the Company’s Board. On March 26, 2026, the Company sent this stockholder a letter notifying such stockholder that its purported nominations were invalid based on various matters and deficiencies identified in connection with the nomination notice. On April 2, 2026, this stockholder filed a complaint with the Court of Chancery of the State of Delaware (the “Court”) against the Company and its Board alleging that the Company’s Board took actions to reject the stockholder’s purported nominations in breach of their fiduciary duties (the “Complaint”). The Complaint alleges, among other things, the following: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="width: 39px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">the Board inappropriately rejected the stockholder’s director nominees;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td> the Company improperly made a dilutive issuance of common stock when the Company completed the March 2026 equity offering (the “March Equity Offering”) (see Note 9) with a stockholder who the complainant believes is aligned with the Board, which the stockholder believes will impact any proxy fight in the Company’s favor, and; </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td>·</td> <td style="text-align: justify">the Company’s Board improperly adopted the Stockholder Rights Plan with a 12.5% ownership trigger (see Note 9) in response to the rapid accumulation of the Company’s stock by this stockholder. </td></tr> </table> The stockholder’s Complaint requests, among other items, that the Court find that (a) the defendants breached their financial duties, (b) undo the Company’s rejection of the stockholder’s nominations for the Company’s Board so that the stockholder’s nominees can be included on the ballot for potential election at the Company’s upcoming 2026 annual meeting, (c) prohibit holders of shares issued in connection with March Equity Offering from being eligible to vote such shares for directors at the Company’s upcoming 2026 annual meeting, and (d) award damages and other monetary relief for the harm caused by the March 2026 equity issuance, together with pre-judgment and post-judgment interest. Discovery for this matter has begun and a tentative trial date has been scheduled to start on June 30, 2026. The Company intends to vigorously defend itself and the Board against the Complaint for the benefit of the stockholders.

false false false false